<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32560789</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0065-2660</ISSN><JournalIssue CitedMedium="Internet"><Volume>105</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Advances in genetics</Title><ISOAbbreviation>Adv Genet</ISOAbbreviation></Journal><ArticleTitle>Application of yeast to studying amyloid and prion diseases.</ArticleTitle><Pagination><StartPage>293</StartPage><EndPage>380</EndPage><MedlinePgn>293-380</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/bs.adgen.2020.01.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0065-2660(20)30002-X</ELocationID><Abstract><AbstractText>Amyloids are fibrous cross-&#x3b2; protein aggregates that are capable of proliferation via nucleated polymerization. Amyloid conformation likely represents an ancient protein fold and is linked to various biological or pathological manifestations. Self-perpetuating amyloid-based protein conformers provide a molecular basis for transmissible (infectious or heritable) protein isoforms, termed prions. Amyloids and prions, as well as other types of misfolded aggregated proteins are associated with a variety of devastating mammalian and human diseases, such as Alzheimer's, Parkinson's and Huntington's diseases, transmissible spongiform encephalopathies (TSEs), amyotrophic lateral sclerosis (ALS) and transthyretinopathies. In yeast and fungi, amyloid-based prions control phenotypically detectable heritable traits. Simplicity of cultivation requirements and availability of powerful genetic approaches makes yeast Saccharomyces cerevisiae an excellent model system for studying molecular and cellular mechanisms governing amyloid formation and propagation. Genetic techniques allowing for the expression of mammalian or human amyloidogenic and prionogenic proteins in yeast enable researchers to capitalize on yeast advantages for characterization of the properties of disease-related proteins. Chimeric constructs employing mammalian and human aggregation-prone proteins or domains, fused to fluorophores or to endogenous yeast proteins allow for cytological or phenotypic detection of disease-related protein aggregation in yeast cells. Yeast systems are amenable to high-throughput screening for antagonists of amyloid formation, propagation and/or toxicity. This review summarizes up to date achievements of yeast assays in application to studying mammalian and human disease-related aggregating proteins, and discusses both limitations and further perspectives of yeast-based strategies.</AbstractText><CopyrightInformation>&#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chernoff</LastName><ForeName>Yury O</ForeName><Initials>YO</Initials><AffiliationInfo><Affiliation>School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, United States; Laboratory of Amyloid Biology, St. Petersburg State University, St. Petersburg, Russia. Electronic address: yury.chernoff@biology.gatech.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grizel</LastName><ForeName>Anastasia V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Laboratory of Amyloid Biology, St. Petersburg State University, St. Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubel</LastName><ForeName>Aleksandr A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Laboratory of Amyloid Biology, St. Petersburg State University, St. Petersburg, Russia; Department of Genetics and Biotechnology, St. Petersburg State University, St. Petersburg, Russia; Sirius University of Science and Technology, Sochi, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zelinsky</LastName><ForeName>Andrew A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Laboratory of Amyloid Biology, St. Petersburg State University, St. Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandramowlishwaran</LastName><ForeName>Pavithra</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chernova</LastName><ForeName>Tatiana A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P50 AG025688</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P51 OD011132</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Adv Genet</MedlineTA><NlmUniqueID>0370421</NlmUniqueID><ISSNLinking>0065-2660</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011328">Prions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000686" MajorTopicYN="N">Amyloidosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017096" MajorTopicYN="N">Prion Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011328" MajorTopicYN="N">Prions</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">Amyloid &#x3b2;</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Huntington's disease</Keyword><Keyword MajorTopicYN="N">Parkinson's disease</Keyword><Keyword MajorTopicYN="N">Prion protein</Keyword><Keyword MajorTopicYN="N">Protein aggregation</Keyword><Keyword MajorTopicYN="N">Tau</Keyword><Keyword MajorTopicYN="N">Transthyretin</Keyword><Keyword MajorTopicYN="N">&#x3b1;-Synuclein</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32560789</ArticleId><ArticleId IdType="mid">NIHMS1629026</ArticleId><ArticleId IdType="pmc">PMC7527210</ArticleId><ArticleId IdType="doi">10.1016/bs.adgen.2020.01.002</ArticleId><ArticleId IdType="pii">S0065-2660(20)30002-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aguzzi A, &amp; Lakkaraju AK (2015). Cell biology of prions and prionoids: A status report. Trends in Cell Biology, 26(1), 40&#x2013;51. 10.1016/j.tcb.2015.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2015.08.007</ArticleId><ArticleId IdType="pubmed">26455408</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguzzi A, &amp; O&#x2019;Connor T (2010). Protein aggregation diseases: Pathogenicity and therapeutic perspectives. Nature Reviews. Drug Discovery, 9(3), 237&#x2013;248. 10.1038/nrd3050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd3050</ArticleId><ArticleId IdType="pubmed">20190788</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed AB, &amp; Kajava AV (2013). Breaking the amyloidogenicity code: Methods to predict amyloids from amino acid sequence. FEBS Letters, 587(8), 1089&#x2013;1095. 10.1016/j.febslet.2012.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2012.12.006</ArticleId><ArticleId IdType="pubmed">23262221</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed AB, Znassi N, Chateau MT, &amp; Kajava AV (2015). A structure-based approach to predict predisposition to amyloidosis. Alzheimers Dement, 11(6), 681&#x2013;690. 10.1016/j.jalz.2014.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2014.06.007</ArticleId><ArticleId IdType="pubmed">25150734</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti S, Halfmann R, King O, Kapila A, &amp; Lindquist S (2009). A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell, 137(1), 146&#x2013;158. doi:S0092-8674(09)00266-9 [pii]. 10.1016/j.cell.2009.02.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.02.044</ArticleId><ArticleId IdType="pmc">PMC2683788</ArticleId><ArticleId IdType="pubmed">19345193</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen KD, Chernova TA, Tennant EP, Wilkinson KD, &amp; Chernoff YO (2007). Effects of ubiquitin system alterations on the formation and loss of a yeast prion. The Journal of Biological Chemistry, 282(5), 3004&#x2013;3013. doi:M609597200 [pii]. 10.1074/jbc.M609597200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M609597200</ArticleId><ArticleId IdType="pubmed">17142456</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso Vilatela ME, Lopez-Lopez M, &amp; Yescas-Gomez P (2012). Genetics of Alzheimer&#x2019;s disease. Archives of Medical Research, 43(8), 622&#x2013;631. 10.1016/j.arcmed.2012.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2012.10.017</ArticleId><ArticleId IdType="pubmed">23142261</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s A (2016). 2016 Alzheimer&#x2019;s disease facts and figures. Alzheimers Dement, 12(4), 459&#x2013;509. 10.1016/j.jalz.2016.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2016.03.001</ArticleId><ArticleId IdType="pubmed">27570871</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreadis A, Brown WM, &amp; Kosik KS (1992). Structure and novel exons of the human tau gene. Biochemistry, 31(43), 10626&#x2013;10633. 10.1021/bi00158a027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00158a027</ArticleId><ArticleId IdType="pubmed">1420178</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonets KS, &amp; Nizhnikov AA (2013). SARP: A novel algorithm to assess compositional biases in protein sequences. Evolutionary Bioinformatics Online, 9, 263&#x2013;273. 10.4137/EBO.S12299.</Citation><ArticleIdList><ArticleId IdType="doi">10.4137/EBO.S12299</ArticleId><ArticleId IdType="pmc">PMC3728207</ArticleId><ArticleId IdType="pubmed">23919085</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonets KS, &amp; Nizhnikov AA (2017). Predicting amyloidogenic proteins in the proteomes of plants. International Journal of Molecular Sciences, 18(10), 2155 10.3390/ijms18102155.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18102155</ArticleId><ArticleId IdType="pmc">PMC5666836</ArticleId><ArticleId IdType="pubmed">29035294</ArticleId></ArticleIdList></Reference><Reference><Citation>Antony H, Wiegmans AP, Wei MQ, Chernoff YO, Khanna KK, &amp;Munn AL (2012). Potential roles for prions and protein-only inheritance in cancer. Cancer Metastasis Reviews, 31(1&#x2013;2), 1&#x2013;19. 10.1007/s10555-011-9325-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10555-011-9325-9</ArticleId><ArticleId IdType="pmc">PMC3315606</ArticleId><ArticleId IdType="pubmed">22138778</ArticleId></ArticleIdList></Reference><Reference><Citation>Apodaca J, Kim I, &amp; Rao H (2006). Cellular tolerance of prion protein PrP in yeast involves proteolysis and the unfolded protein response. Biochemical and Biophysical Research Communications, 347(1), 319&#x2013;326. 10.1016/j.bbrc.2006.06.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.06.078</ArticleId><ArticleId IdType="pubmed">16808901</ArticleId></ArticleIdList></Reference><Reference><Citation>Armakola M, Higgins MJ, Figley MD, Barmada SJ, Scarborough EA, Diaz Z, et al. (2012). Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. Nature Genetics, 44(12), 1302&#x2013;1309. 10.1038/ng.2434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2434</ArticleId><ArticleId IdType="pmc">PMC3510335</ArticleId><ArticleId IdType="pubmed">23104007</ArticleId></ArticleIdList></Reference><Reference><Citation>Arslan F, Hong JY, Kanneganti V, Park SK, &amp; Liebman SW (2015). Heterologous aggregates promote de novo prion appearance via more than one mechanism. PLoS Genetics, 11(1), e1004814 10.1371/journal.pgen.1004814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1004814</ArticleId><ArticleId IdType="pmc">PMC4287349</ArticleId><ArticleId IdType="pubmed">25568955</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash PE, Bieniek KF, Gendron TF, Caulfield T, Lin WL, Dejesus-Hernandez M, et al. (2013). Unconventional translation of C9ORF72 GGGGCC expansion generates insolublepolypeptides specific to c9FTD/ALS. Neuron, 77(4), 639&#x2013;646. 10.1016/j.neuron.2013.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.004</ArticleId><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala YM, Zago P, D&#x2019;Ambrogio A, Xu YF, Petrucelli L, Buratti E, et al. (2008). Structural determinants of the cellular localization and shuttling of TDP-43. Journal of Cell Science, 121 (Pt. 22), 3778&#x2013;3785. 10.1242/jcs.038950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.038950</ArticleId><ArticleId IdType="pubmed">18957508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI, &amp; Cashman NR (2018). Prion-like mechanisms in amyotrophic lateral sclerosis. Handbook of Clinical Neurology, 153, 337&#x2013;354. 10.1016/B978-0-444-63945-5.00018-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63945-5.00018-0</ArticleId><ArticleId IdType="pubmed">29887144</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI, Fromholt SE, O&#x2019;Neal VM, Diamond JH, &amp; Borchelt DR (2016). Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways. Acta Neuropathologica, 131(1), 103&#x2013;114. 10.1007/s00401-015-1514-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1514-0</ArticleId><ArticleId IdType="pmc">PMC4699876</ArticleId><ArticleId IdType="pubmed">26650262</ArticleId></ArticleIdList></Reference><Reference><Citation>Bach S, Talarek N, Andrieu T, Vierfond JM, Mettey Y, Galons H, et al. (2003). Isolation of drugs active against mammalian prions using a yeast-based screening assay. Nature Biotechnology, 21(9), 1075&#x2013;1081. 10.1038/nbt855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt855</ArticleId><ArticleId IdType="pubmed">12910243</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnhart MM, &amp; Chapman MR (2006). Curli biogenesis and function. Annual Review of Microbiology, 60, 131&#x2013;147. 10.1146/annurev.micro.60.080805.142106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.micro.60.080805.142106</ArticleId><ArticleId IdType="pmc">PMC2838481</ArticleId><ArticleId IdType="pubmed">16704339</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastow EL, Peswani AR, Tarrant DS, Pentland DR, Chen X, Morgan A, et al. (2016). New links between SOD1 and metabolic dysfunction from a yeast model of amyotrophic lateral sclerosis. Journal of Cell Science, 129(21), 4118&#x2013;4129. 10.1242/jcs.190298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.190298</ArticleId><ArticleId IdType="pmc">PMC5117206</ArticleId><ArticleId IdType="pubmed">27656112</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker LA, Huang B, Bieri G, Ma R, Knowles DA, Jafar-Nejad P, et al. (2017). Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature, 544(7650), 367&#x2013;371. 10.1038/nature22038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22038</ArticleId><ArticleId IdType="pmc">PMC5642042</ArticleId><ArticleId IdType="pubmed">28405022</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrends C, Langer CA, Boteva R, Bottcher UM, Stemp MJ, Schaffar G, et al. (2006). Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers. Molecular Cell, 23(6), 887&#x2013;897. https://doi.org/10.10167j.molcel.2006.08.017.</Citation><ArticleIdList><ArticleId IdType="pubmed">16973440</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett CL,&amp; La Spada AR (2018). Senataxin, A novel helicase at the interface of RNA transcriptome regulation and neurobiology: From normal function to pathological roles in motor neuron disease and cerebellar degeneration. Advances in Neurology, 20, 265&#x2013;281. 10.1007/978-3-319-89689-2_10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-89689-2_10</ArticleId><ArticleId IdType="pubmed">29916023</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezsonov EE, Groenning M, Galzitskaya OV, Gorkovskii AA, Semisotnov GV, Selyakh IO, et al. (2013). Amyloidogenic peptides of yeast cell wall glucantransferase Bgl2p as a model for the investigation of its pH-dependent fibril formation. Prion, 7(2), 175&#x2013;184. 10.4161/pri.22992.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.22992</ArticleId><ArticleId IdType="pmc">PMC3609127</ArticleId><ArticleId IdType="pubmed">23208381</ArticleId></ArticleIdList></Reference><Reference><Citation>Bharadwaj P, Waddington L, Varghese J, &amp; Macreadie IG (2008). A new method to measure cellular toxicity of non-fibrillar and fibrillar Alzheimer&#x2019;s Abeta using yeast. Journal of Alzheimer&#x2019;s Disease, 13(2), 147&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">18376056</ArticleId></ArticleIdList></Reference><Reference><Citation>Bharadwaj PR, Verdile G, Barr RK, Gupta V, Steele JW, Lachenmayer ML, et al. (2012). Latrepirdine (dimebon) enhances autophagy and reduces intracellular GFP-Abeta42 levels in yeast. Journal of Alzheimer&#x2019;s Disease, 32(4), 949&#x2013;967. 10.3233/JAD-2012-120178.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2012-120178</ArticleId><ArticleId IdType="pmc">PMC3529125</ArticleId><ArticleId IdType="pubmed">22903131</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigio EH, Wu JY, Deng HX, Bit-Ivan EN, Mao Q, Ganti R, et al. (2013). Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid. Acta Neuropathologica, 125(3), 463&#x2013;465. 10.1007/s00401-013-1089-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1089-6</ArticleId><ArticleId IdType="pmc">PMC3593646</ArticleId><ArticleId IdType="pubmed">23378033</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco LP, Evans ML, Smith DR, Badtke MP, &amp; Chapman MR (2012). Diversity, biogenesis and function of microbial amyloids. Trends in Microbiology, 20(2), 66&#x2013;73. 10.1016/j.tim.2011.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2011.11.005</ArticleId><ArticleId IdType="pmc">PMC3278576</ArticleId><ArticleId IdType="pubmed">22197327</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolognesi B, Faure AJ, Seuma M, Schmiedel JM, Tartaglia GG, &amp; Lehner B (2019). The mutational landscape of a prion-like domain. Nature Communications, 10(1). 4162.10.1038/s41467-019-12101-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12101-z</ArticleId><ArticleId IdType="pmc">PMC6744496</ArticleId><ArticleId IdType="pubmed">31519910</ArticleId></ArticleIdList></Reference><Reference><Citation>Bras IC, Popova B, Braus GH, &amp; Outeiro TF (2019). Yeast-based screens to target alpha-synuclein toxicity. Methods in Molecular Biology, 1948, 145&#x2013;156. 10.1007/978-1-4939-9124-2_12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-9124-2_12</ArticleId><ArticleId IdType="pubmed">30771176</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun RJ, Sommer C, Carmona-Gutierrez D, Khoury CM, Ring J, Buttner S, et al. (2011). Neurotoxic 43-kDa TAR DNA-binding protein (TDP-43) triggers mitochondrion-dependent programmed cell death in yeast. The Journal of Biological Chemistry, 286(22), 19958&#x2013;19972. 10.1074/jbc.M110.194852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.194852</ArticleId><ArticleId IdType="pmc">PMC3103370</ArticleId><ArticleId IdType="pubmed">21471218</ArticleId></ArticleIdList></Reference><Reference><Citation>Buhimschi IA, Nayeri UA, Zhao G, Shook LL, Pensalfini A, Funai EF, et al. (2014). Protein misfolding, congophilia, oligomerization, and defective amyloid processing in preeclampsia. Science Translational Medicine, 6(245), 245ra292 10.1126/scitranslmed.3008808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3008808</ArticleId><ArticleId IdType="pubmed">25031267</ArticleId></ArticleIdList></Reference><Reference><Citation>Caine J, Sankovich S, Antony H, Waddington L, Macreadie P, Varghese J, et al. (2007). Alzheimer&#x2019;s Abeta fused to green fluorescent protein induces growth stress and a heat shock response. FEMS Yeast Research, 7(8), 1230&#x2013;1236. 10.1111/j.1567-1364.2007.00285.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1567-1364.2007.00285.x</ArticleId><ArticleId IdType="pubmed">17662055</ArticleId></ArticleIdList></Reference><Reference><Citation>Campesan S, Green EW, Breda C, Sathyasaikumar KV, Muchowski PJ, Schwarcz R, et al. (2011). The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington&#x2019;s disease. Current Biology, 21(11), 961&#x2013;966. 10.1016/j.cub.2011.04.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2011.04.028</ArticleId><ArticleId IdType="pmc">PMC3929356</ArticleId><ArticleId IdType="pubmed">21636279</ArticleId></ArticleIdList></Reference><Reference><Citation>Capellari S, Baiardi S, Rinaldi R, Bartoletti-Stella A, Graziano C, Piras S, et al. (2018). Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis. Annals of Clinical Translational Neurology, 5(6), 777&#x2013;783. 10.1002/acn3.568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.568</ArticleId><ArticleId IdType="pmc">PMC5989776</ArticleId><ArticleId IdType="pubmed">29928661</ArticleId></ArticleIdList></Reference><Reference><Citation>Capitini C, Conti S, Perni M, Guidi F, Cascella R, De Poli A, et al. (2014). TDP-43 inclusion bodies formed in bacteria are structurally amorphous, non-amyloid and inherently toxic to neuroblastoma cells. PLoS One, 9(1), e86720 10.1371/journal.pone.0086720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0086720</ArticleId><ArticleId IdType="pmc">PMC3907574</ArticleId><ArticleId IdType="pubmed">24497973</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascarina SM, Paul KR, Machihara S, &amp; Ross ED (2018). Sequence features governing aggregation or degradation of prion-like proteins. PLoS Genetics, 14(7), e1007517 10.1371/journal.pgen.1007517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007517</ArticleId><ArticleId IdType="pmc">PMC6059496</ArticleId><ArticleId IdType="pubmed">30005071</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellani RJ, Plascencia-Villa G, &amp; Perry G (2019). The amyloid cascade and Alzheimer&#x2019;s disease therapeutics: Theory versus observation. Laboratory Investigation, 99(7), 958&#x2013;970. 10.1038/s41374-019-0231-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41374-019-0231-z</ArticleId><ArticleId IdType="pubmed">30760863</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai N, &amp; Gitler AD (2018). Yeast screen for modifiers of C9orf72 poly(glycine-arginine) dipeptide repeat toxicity. FEMS Yeast Research, 18(4), foy024 10.1093/femsyr/foy024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/femsyr/foy024</ArticleId><ArticleId IdType="pmc">PMC5946852</ArticleId><ArticleId IdType="pubmed">29528392</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrabortee S, Byers JS, Jones S, Garcia DM, Bhullar B, Chang A, et al. (2016). Intrinsically disordered proteins drive emergence and inheritance of biological traits. Cell, 167(2), 369&#x2013;381.e12. 10.1016/jxen.2016.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/jxen.2016.09.017</ArticleId><ArticleId IdType="pmc">PMC5066306</ArticleId><ArticleId IdType="pubmed">27693355</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandramowlishwaran P, Sun M, Casey KL, Romanyuk AV, Grizel AV, Sopova JV, et al. (2018). Mammalian amyloidogenic proteins promote prion nucleation in yeast. The Journal of Biological Chemistry, 293(9), 3436&#x2013;3450. 10.1074/jbc.M117.809004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.809004</ArticleId><ArticleId IdType="pmc">PMC5836139</ArticleId><ArticleId IdType="pubmed">29330303</ArticleId></ArticleIdList></Reference><Reference><Citation>Charco JM, Erana H, Venegas V, Garcia-Martinez S, Lopez-Moreno R, Gonzalez-Miranda E, et al. (2017). Recombinant PrP and its contribution to research on transmissible spongiform encephalopathies. Pathogens, 6(4), 67 10.3390/pathogens6040067.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens6040067</ArticleId><ArticleId IdType="pmc">PMC5750591</ArticleId><ArticleId IdType="pubmed">29240682</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Yadav SP, &amp; Surewicz WK (2010). Interactionbetween human prionprotein and amyloid-beta (Abeta) oligomers: Role OF N-terminal residues. The Journal of Biological Chemistry, 285(34), 26377&#x2013;26383. 10.1074/jbc.M110.145516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.145516</ArticleId><ArticleId IdType="pmc">PMC2924066</ArticleId><ArticleId IdType="pubmed">20576610</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernoff YO (2001). Mutation processes at the protein level: Is Lamarck back? Mutation Research, 488(1), 39&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">11223404</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernoff YO (2007). Stress and prions: Lessons from the yeast model. FEBS Letters, 581(19), 3695&#x2013;3701, doi:S0014-5793(07)00474-7 [pii]. 10.1016/j.febslet.2007.04.075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2007.04.075</ArticleId><ArticleId IdType="pmc">PMC2695654</ArticleId><ArticleId IdType="pubmed">17509571</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernoff YO, Derkach IL, &amp; Inge-Vechtomov SG (1993). Multicopy SUP35 gene induces de-novo appearance of psi-like factors in the yeast Saccharomyces cerevisiae. Current Genetics, 24(3), 268&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="pubmed">8221937</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernoff YO, Lindquist SL, Ono B, Inge-Vechtomov SG, &amp; Liebman SW (1995). Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science, 268(5212), 880&#x2013;884.</Citation><ArticleIdList><ArticleId IdType="pubmed">7754373</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernoff YO, Newnam GP, Kumar J, Allen K, &amp; Zink AD (1999). Evidence for a protein mutator in yeast: Role of the Hsp70-related chaperone ssb in formation, stability, and toxicity of the [PSI] prion. Molecular and Cellular Biology, 19(12), 8103&#x2013;8112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC84895</ArticleId><ArticleId IdType="pubmed">10567536</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernova TA, Chernoff YO, &amp; Wilkinson KD (2017). Prion-based memory of heat stress in yeast. Prion, 11(3), 151&#x2013;161. 10.1080/19336896.2017.1328342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2017.1328342</ArticleId><ArticleId IdType="pmc">PMC5480388</ArticleId><ArticleId IdType="pubmed">28521568</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernova TA, ChernofF YO, &amp; Wilkinson KD (2019). Yeast models for amyloids and prions: Environmental modulation and drug discovery. Molecules, 24(18), E3388 10.3390/molecules24183388.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24183388</ArticleId><ArticleId IdType="pmc">PMC6767215</ArticleId><ArticleId IdType="pubmed">31540362</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernova TA, Kiktev DA, Romanyuk AV, Shanks JR, Laur O, Ali M, et al. (2017). Yeast short-lived actin-associated protein forms a metastable prion in response to thermal stress. Cell Reports, 18(3), 751&#x2013;761. 10.1016/jxelrep.2016.12.082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/jxelrep.2016.12.082</ArticleId><ArticleId IdType="pmc">PMC5267347</ArticleId><ArticleId IdType="pubmed">28099852</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernova TA, Romanyuk AV, Karpova TS, Shanks JR, Ali M, Moffatt N, et al. (2011). Prion induction by the short-lived, stress-induced protein Lsb2 is regulated by ubiquitination and association with the actin cytoskeleton. Molecular Cell, 43(2), 242&#x2013;252. 10.1016/j.molcel.2011.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2011.07.001</ArticleId><ArticleId IdType="pmc">PMC3151368</ArticleId><ArticleId IdType="pubmed">21777813</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernova TA, Wilkinson KD, &amp; Chernoff YO (2014). Physiological and environmental control of yeast prions. FEMS Microbiology Reviews, 38(2), 326&#x2013;344. 10.1111/1574-6976.12053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1574-6976.12053</ArticleId><ArticleId IdType="pmc">PMC3951574</ArticleId><ArticleId IdType="pubmed">24236638</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernova TA, Wilkinson KD, &amp; Chernoff YO (2017). Prions, chaperones, and proteostasis in yeast. Cold Spring Harbor Perspectives in Biology, 9(2), a023663 10.1101/cshperspect.a023663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a023663</ArticleId><ArticleId IdType="pmc">PMC5287078</ArticleId><ArticleId IdType="pubmed">27815300</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, et al. (2001). Treatment with a copper-zinc chelator markedly and rapidly inhibits betaamyloid accumulation in Alzheimer&#x2019;s disease transgenic mice. Neuron, 30(3), 665&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pubmed">11430801</ArticleId></ArticleIdList></Reference><Reference><Citation>Chesi A, Staahl BT, Jovicic A, Couthouis J, Fasolino M, Raphael AR, et al. (2013). Exome sequencing to identify de novo mutations in sporadic ALS trios. Nature Neuroscience, 16(7), 851&#x2013;855. 10.1038/nn.3412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3412</ArticleId><ArticleId IdType="pmc">PMC3709464</ArticleId><ArticleId IdType="pubmed">23708140</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciaccioli G, Martins A, Rodrigues C, Vieira H, &amp; Calado P (2013). A powerful yeast model to investigate the synergistic interaction of alpha-synuclein and tau in neurodegeneration. PLoS One, 8(2), e55848 10.1371/journal.pone.0055848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0055848</ArticleId><ArticleId IdType="pmc">PMC3564910</ArticleId><ArticleId IdType="pubmed">23393603</ArticleId></ArticleIdList></Reference><Reference><Citation>Colby DW, &amp; Prusiner SB (2011). Prions. Cold Spring Harbor Perspectives in Biology, 3(1), a006833 10.1101/cshperspect.a006833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a006833</ArticleId><ArticleId IdType="pmc">PMC3003464</ArticleId><ArticleId IdType="pubmed">21421910</ArticleId></ArticleIdList></Reference><Reference><Citation>Collinge J (1997). Human prion diseases and bovine spongiform encephalopathy (BSE). Human Molecular Genetics, 6(10), 1699&#x2013;1705. 10.1093/hmg/6.10.1699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/6.10.1699</ArticleId><ArticleId IdType="pubmed">9300662</ArticleId></ArticleIdList></Reference><Reference><Citation>Conchillo-Sole O, de Groot NS, Aviles FX, Vendrell J, Daura X, &amp; Ventura S (2007). AGGRESCAN: A server for the prediction and evaluation of &#x201c;hot spots&#x201d; of aggregation in polypeptides. BMC Bioinformatics, 8, 65 10.1186/1471-2105-8-65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-8-65</ArticleId><ArticleId IdType="pmc">PMC1828741</ArticleId><ArticleId IdType="pubmed">17324296</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors LH, Lim A, Prokaeva T, Roskens VA, &amp; Costello CE (2003). Tabulation of human transthyretin (TTR) variants, 2003. Amyloid, 10(3), 160&#x2013;184. 10.3109/13506120308998998.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13506120308998998</ArticleId><ArticleId IdType="pubmed">14640030</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B, et al. (2006). Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson&#x2019;s models. Science, 313(5785), 324&#x2013;328. 10.1126/science.1129462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1129462</ArticleId><ArticleId IdType="pmc">PMC1983366</ArticleId><ArticleId IdType="pubmed">16794039</ArticleId></ArticleIdList></Reference><Reference><Citation>Couratier P, Corcia P, Lautrette G, Nicol M, &amp; Marin B (2017). ALS and frontotemporal dementia belong to a common disease spectrum. Revue Neurologique (Paris), 173(5), 273&#x2013;279. 10.1016/j.neurol.2017.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2017.04.001</ArticleId><ArticleId IdType="pubmed">28449882</ArticleId></ArticleIdList></Reference><Reference><Citation>Coustou V, Deleu C, Saupe S, &amp; Begueret J (1997). The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proceedings of the National Academy of Sciences of the United States of America, 94(18), 9773&#x2013;9778.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC23266</ArticleId><ArticleId IdType="pubmed">9275200</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox B, &amp; Tuite M (2018). The life of [PSI]. Current Genetics, 64(1), 1&#x2013;8. 10.1007/s00294-017-0714-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00294-017-0714-7</ArticleId><ArticleId IdType="pmc">PMC5778180</ArticleId><ArticleId IdType="pubmed">28653109</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox BS (1965). &#x3c8;, A cytoplasmic suppressor of super-suppressor in yeast. Heredity, 20, 505&#x2013;521.</Citation></Reference><Reference><Citation>Cox BS, Byrne LJ, &amp; Tuite MF (2007). Prion stability. Prion, 1(3), 170&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2634590</ArticleId><ArticleId IdType="pubmed">19164897</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin-Furman EN, Barber-Singh J, Bergquist KE, Yagi T, &amp; Trimmer PA (2019). Differential effects of yeast NADH dehydrogenase (Ndi1) expression on mitochondrial function and inclusion formation in a cell culture model of sporadic Parkinson&#x2019;s disease. Biomolecules, 9(4), 119 10.3390/biom9040119.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom9040119</ArticleId><ArticleId IdType="pmc">PMC6523508</ArticleId><ArticleId IdType="pubmed">30934776</ArticleId></ArticleIdList></Reference><Reference><Citation>Cushman M, Johnson BS, King OD, Gitler AD, &amp; Shorter J (2010). Prion-like disorders: Blurring the divide between transmissibility and infectivity. Journal of Cell Science, 123(Pt. 8), 1191&#x2013;1201. 10.1242/jcs.051672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.051672</ArticleId><ArticleId IdType="pmc">PMC2848109</ArticleId><ArticleId IdType="pubmed">20356930</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Angelo F, Vignaud H, Di Martino J, Salin B, Devin A, Cullin C, et al. (2013). A yeast model for amyloid-beta aggregation exemplifies the role of membrane trafficking and PICALM in cytotoxicity. Disease Models &amp; Mechanisms, 6(1), 206&#x2013;216. 10.1242/dmm.010108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.010108</ArticleId><ArticleId IdType="pmc">PMC3529352</ArticleId><ArticleId IdType="pubmed">22888099</ArticleId></ArticleIdList></Reference><Reference><Citation>Daigle JG, Lanson NA Jr., Smith RB, Casci I, Maltare A, Monaghan J, et al. (2013). RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations. Human Molecular Genetics, 22(6), 1193&#x2013;1205. 10.1093/hmg/dds526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds526</ArticleId><ArticleId IdType="pmc">PMC3578413</ArticleId><ArticleId IdType="pubmed">23257289</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos A, Anandhakumar J, Van den Brande J, Verduyckt M, Franssens V, Winderickx J, et al. (2011). Yeast as a model system to study tau biology. International Journal of Alzheimer&#x2019;s Disease, 2011, 428970 10.4061/2011/428970.</Citation><ArticleIdList><ArticleId IdType="doi">10.4061/2011/428970</ArticleId><ArticleId IdType="pmc">PMC3090044</ArticleId><ArticleId IdType="pubmed">21559193</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. (2011). Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron, 72(2), 245&#x2013;256. https://doi.org/10.1016Zj.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Derkatch IL, Bradley ME, Hong JY, &amp; Liebman SW (2001). Prions affect the appearance of other prions: The story of [PIN(+)]. Cell, 106(2), 171&#x2013;182. doi:S0092-8674(01)00427-5 [pii].</Citation><ArticleIdList><ArticleId IdType="pubmed">11511345</ArticleId></ArticleIdList></Reference><Reference><Citation>Derkatch IL, Bradley ME, Zhou P, Chernoff YO, &amp; Liebman SW (1997). Genetic and environmental factors affecting the de novo appearance of the [PSI +] prion in Saccharomyces cerevisiae. Genetics, 147(2), 507&#x2013;519.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1208174</ArticleId><ArticleId IdType="pubmed">9335589</ArticleId></ArticleIdList></Reference><Reference><Citation>Derkatch IL, Chernoff YO, Kushnirov VV, Inge-Vechtomov SG, &amp; Liebman SW (1996). Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics, 144(4), 1375&#x2013;1386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1207691</ArticleId><ArticleId IdType="pubmed">8978027</ArticleId></ArticleIdList></Reference><Reference><Citation>Derkatch IL, Uptain SM, Outeiro TF, Krishnan R, Lindquist SL, &amp; Liebman SW (2004). Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. Proceedings of the National Academy of Sciences of the United States of America, 101(35), 12934&#x2013;12939. 10.1073/pnas.04049681010404968101ipii].</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.04049681010404968101ipii</ArticleId><ArticleId IdType="pmc">PMC516497</ArticleId><ArticleId IdType="pubmed">15326312</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gregorio SE, &amp; Duennwald ML (2018). ALS yeast models-past success stories and new opportunities. Frontiers in Molecular Neuroscience, 11, 394 10.3389/fnmol.2018.00394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00394</ArticleId><ArticleId IdType="pmc">PMC6218427</ArticleId><ArticleId IdType="pubmed">30425620</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon C, Mathias N, Zweig RM, Davis DA, &amp; Gross DS (2005). Alpha-synuclein targets the plasma membrane via the secretory pathway and induces toxicity in yeast. Genetics, 170(1), 47&#x2013;59. 10.1534/genetics.104.035493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.104.035493</ArticleId><ArticleId IdType="pmc">PMC1449710</ArticleId><ArticleId IdType="pubmed">15744056</ArticleId></ArticleIdList></Reference><Reference><Citation>Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO, et al. (2008). Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer&#x2019;s disease: A randomised, double-blind, placebo-controlled study. Lancet, 372(9634), 207&#x2013;215. 10.1016/S0140-6736(08)61074-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)61074-0</ArticleId><ArticleId IdType="pubmed">18640457</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D, Madl T, Valori CF, Bentmann E, Tahirovic S, Abou-Ajram C, et al. (2012). Arginine methylation next to the PY-NLS modulates transportin binding and nuclear import of FUS. The EMBO Journal, 31(22), 4258&#x2013;4275. 10.1038/emboj.2012.261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.261</ArticleId><ArticleId IdType="pmc">PMC3501225</ArticleId><ArticleId IdType="pubmed">22968170</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D, Rodde R, Edbauer D, Bentmann E, Fischer I, Hruscha A, et al. (2010). ALS-associated fused in sarcoma (FUS) mutations disrupt transportin-mediated nuclear import. The EMBO Journal, 29(16), 2841&#x2013;2857. 10.1038/emboj.2010.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.143</ArticleId><ArticleId IdType="pmc">PMC2924641</ArticleId><ArticleId IdType="pubmed">20606625</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Z, Park KW, Yu H, Fan Q, &amp; Li L (2008). Newly identified prion linked to the chromatin-remodeling factor Swi1 in Saccharomyces cerevisiae. Nature Genetics, 40(4), 460&#x2013;465, doi:ng.112 [pii]. 10.1038/ng.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.112</ArticleId><ArticleId IdType="pmc">PMC2633598</ArticleId><ArticleId IdType="pubmed">18362884</ArticleId></ArticleIdList></Reference><Reference><Citation>Duennwald ML (2013). Yeast as a platform to explore polyglutamine toxicity and aggregation. Methods in Molecular Biology, 1017, 153&#x2013;161. 10.1007/978-1-62703-438-8_11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-62703-438-8_11</ArticleId><ArticleId IdType="pubmed">23719914</ArticleId></ArticleIdList></Reference><Reference><Citation>Duernberger Y, Liu S, Riemschoss K, Paulsen L, Bester R, Kuhn PH, et al. (2018). Prion replication in the mammalian cytosol: Functional regions within a prion domain driving induction, propagation, and inheritance. Molecular and Cellular Biology, 38(15), e00111&#x2013;18. 10.1128/MCB.00111-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00111-18</ArticleId><ArticleId IdType="pmc">PMC6048315</ArticleId><ArticleId IdType="pubmed">29784771</ArticleId></ArticleIdList></Reference><Reference><Citation>Erana H (2019). The Prion 2018 round tables (II): Abeta, tau, alpha-synuclein. are they prions, prion-like proteins, or what? Prion, 13(1), 41&#x2013;45. 10.1080/19336896.2019.1569451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2019.1569451</ArticleId><ArticleId IdType="pmc">PMC6422364</ArticleId><ArticleId IdType="pubmed">30646820</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcon B, Zhang W, Murzin AG, Murshudov G, Garringer HJ, Vidal R, et al. (2018). Structures of filaments from Pick&#x2019;s disease reveal a novel tau protein fold. Nature, 561(7721), 137&#x2013;140. 10.1038/s41586-018-0454-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0454-y</ArticleId><ArticleId IdType="pmc">PMC6204212</ArticleId><ArticleId IdType="pubmed">30158706</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcon B, Zhang W, Schweighauser M, Murzin AG, Vidal R, Garringer HJ, et al. (2018). Tau filaments from multiple cases of sporadic and inherited Alzheimer&#x2019;s disease adopt a common fold. Acta Neuropathologica, 136(5), 699&#x2013;708. 10.1007/s00401-018-1914-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1914-z</ArticleId><ArticleId IdType="pmc">PMC6208733</ArticleId><ArticleId IdType="pubmed">30276465</ArticleId></ArticleIdList></Reference><Reference><Citation>Faria C, Jorge CD, Borges N, Tenreiro S, Outeiro TF, &amp; Santos H (2013). Inhibition of formation of alpha-synuclein inclusions by mannosylglycerate in a yeast model of Parkinson&#x2019;s disease. Biochimica et Biophysica Acta, 1830(8), 4065&#x2013;4072. 10.1016/j.bbagen.2013.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2013.04.015</ArticleId><ArticleId IdType="pubmed">23608058</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiler MS, Strobel B, Freischmidt A, Helferich AM, Kappel J, Brewer BM, et al. (2015). TDP-43 is intercellularly transmitted across axon terminals. The Journal of Cell Biology, 211(4), 897&#x2013;911. 10.1083/jcb.201504057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201504057</ArticleId><ArticleId IdType="pmc">PMC4657165</ArticleId><ArticleId IdType="pubmed">26598621</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes JT, Tenreiro S, Gameiro A, Chu V, Outeiro TF, &amp; Conde JP (2014). Modulation of alpha-synuclein toxicity in yeast using a novel microfluidic-based gradient generator. Lab on a Chip, 14(20), 3949&#x2013;3957. 10.1039/c4lc00756e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c4lc00756e</ArticleId><ArticleId IdType="pubmed">25167219</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Escamilla AM, Rousseau F, Schymkowitz J, &amp; Serrano L (2004). Prediction of sequence-dependent and mutational effects on the aggregation of peptides andproteins. Nature Biotechnology, 22(10), 1302&#x2013;1306. 10.1038/nbt1012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt1012</ArticleId><ArticleId IdType="pubmed">15361882</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari A, Hoerndli F, Baechi T, Nitsch RM, &amp; Gotz J (2003). Beta-amyloid induces paired helical filament-like tau filaments in tissue culture. The Journal of Biological Chemistry, 278(41), 40162&#x2013;40168. 10.1074/jbc.M308243200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M308243200</ArticleId><ArticleId IdType="pubmed">12893817</ArticleId></ArticleIdList></Reference><Reference><Citation>Figley MD, Bieri G, Kolaitis RM, Taylor JP, &amp; Gitler AD (2014). Profilin 1 associates with stress granules and ALS-linked mutations alter stress granule dynamics. The Journal of Neuroscience, 34(24), 8083&#x2013;8097. 10.1523/JNEUROSCI.0543-14.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0543-14.2014</ArticleId><ArticleId IdType="pmc">PMC4051967</ArticleId><ArticleId IdType="pubmed">24920614</ArticleId></ArticleIdList></Reference><Reference><Citation>Figley MD, &amp; Gitler AD (2013). Yeast genetic screen reveals novel therapeutic strategy forALS. Rare Diseases, 1, e24420 10.4161/rdis.24420.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/rdis.24420</ArticleId><ArticleId IdType="pmc">PMC3933050</ArticleId><ArticleId IdType="pubmed">25002991</ArticleId></ArticleIdList></Reference><Reference><Citation>Fioriti L, Myers C, Huang YY, Li X, Stephan JS, TrifiliefF P, et al. (2015). The persistence of hippocampal-based memory requires protein synthesis mediated by the prion-like protein CPEB3. Neuron, 86(6), 1433&#x2013;1448. 10.1016/j.neuron.2015.05.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.05.021</ArticleId><ArticleId IdType="pubmed">26074003</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick AWP, Falcon B, He S, Murzin AG, Murshudov G, Garringer HJ, et al. (2017). Cryo-EM structures of tau Filaments From Alzheimer&#x2019;s disease. Nature, 547(7662), 185&#x2013;190. 10.1038/nature23002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature23002</ArticleId><ArticleId IdType="pmc">PMC5552202</ArticleId><ArticleId IdType="pubmed">28678775</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaherty DB, Soria JP, Tomasiewicz HG, &amp;Wood JG (2000). Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants. Journal of Neuroscience Research, 62(3), 463&#x2013;472. 10.1002/1097-4547(20001101)62:3&lt;463&#x2237;AID-JNR16&gt;3.0.CO;2-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-4547(20001101)62:3&lt;463&#x2237;AID-JNR16&gt;3.0.CO;2-7</ArticleId><ArticleId IdType="pubmed">11054815</ArticleId></ArticleIdList></Reference><Reference><Citation>Flechsig E, &amp; Weissmann C (2004). The role of PrP in health and disease. CurrentMolecular Medicine, 4(4), 337&#x2013;353. 10.2174/1566524043360645.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1566524043360645</ArticleId><ArticleId IdType="pubmed">15354865</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleming J, Outeiro TF, Slack M, Lindquist SL, &amp;Bulawa CE (2008). Detection of compounds that rescue Rab1-synuclein toxicity. Methods in Enzymology, 439, 339&#x2013;351. 10.1016/S0076-6879(07)00425-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0076-6879(07)00425-9</ArticleId><ArticleId IdType="pubmed">18374176</ArticleId></ArticleIdList></Reference><Reference><Citation>Flower TR, Chesnokova LS, Froelich CA, Dixon C, &amp; Witt SN (2005). Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson&#x2019;s disease. Journal of Molecular Biology, 351(5), 1081&#x2013;1100. 10.1016/j.jmb.2005.06.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2005.06.060</ArticleId><ArticleId IdType="pubmed">16051265</ArticleId></ArticleIdList></Reference><Reference><Citation>Flower TR, Clark-Dixon C, Metoyer C, Yang H, Shi R, Zhang Z, et al. (2007). YGR198w (YPP1) targets A30P alpha-synuclein to the vacuole For degradation. The Journal of Cell Biology, 177(6), 1091&#x2013;1104. 10.1083/jcb.200610071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200610071</ArticleId><ArticleId IdType="pmc">PMC2064368</ArticleId><ArticleId IdType="pubmed">17576801</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler DM, &amp; Kelly JW (2012). Functional amyloidogenesis and cytotoxicity-insights into biology and pathology. PLoS Biology, 10(12), e1001459 10.1371/journal.pbio.1001459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1001459</ArticleId><ArticleId IdType="pmc">PMC3531510</ArticleId><ArticleId IdType="pubmed">23300381</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler DM, Koulov AV, Alory-Jost C, Marks MS, Balch WE, &amp; Kelly JW (2006). Functional amyloid Formation within mammalian tissue. PLoS Biology, 4(1), e6 10.1371/journal.pbio.0040006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0040006</ArticleId><ArticleId IdType="pmc">PMC1288039</ArticleId><ArticleId IdType="pubmed">16300414</ArticleId></ArticleIdList></Reference><Reference><Citation>Franzmann TM, Jahnel M, Pozniakovsky A, Mahamid J, Holehouse AS, Nuske E, et al. (2018). Phase separation of a yeast prion protein promotes cellular Fitness. Science, 359(6371), eaao5654 10.1126/science.aao5654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aao5654</ArticleId><ArticleId IdType="pubmed">29301985</ArticleId></ArticleIdList></Reference><Reference><Citation>Frost B, Jacks RL, &amp; Diamond MI (2009). Propagation of tau misfolding from the outside to the inside of a cell. The Journal of Biological Chemistry, 284(19), 12845&#x2013;12852. doi:M808759200 [pii]. 10.1074/jbc.M808759200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M808759200</ArticleId><ArticleId IdType="pmc">PMC2676015</ArticleId><ArticleId IdType="pubmed">19282288</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y, Kaneko K, Watanabe S, Yamanaka K, &amp; Nukina N (2011). A seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions. The Journal of Biological Chemistry, 286(21), 18664&#x2013;18672. 10.1074/jbc.M111.231209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.231209</ArticleId><ArticleId IdType="pmc">PMC3099683</ArticleId><ArticleId IdType="pubmed">21454603</ArticleId></ArticleIdList></Reference><Reference><Citation>Fushimi K, Long C, Jayaram N, Chen X, Li L, &amp; Wu JY (2011). Expression of human FUS/TLS in yeast leads to protein aggregation and cytotoxicity, recapitulating key features of FUS proteinopathy. Protein &amp; Cell, 2(2), 141&#x2013;149. 10.1007/s13238-011-1014-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-011-1014-5</ArticleId><ArticleId IdType="pmc">PMC3093303</ArticleId><ArticleId IdType="pubmed">21327870</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganusova EE, Ozolins LN, Bhagat S, Newnam GP, Wegrzyn RD, Sherman MY, et al. (2006). Modulation of prion formation, aggregation, and toxicity by the actin cytoskeleton in yeast. Molecular and Cellular Biology, 26(2), 617&#x2013;629. 26/2/617 [pii]. 10.1128/MCB.26.2.617-629.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.26.2.617-629.2006</ArticleId><ArticleId IdType="pmc">PMC1346895</ArticleId><ArticleId IdType="pubmed">16382152</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Bieniek KF, Zhang YJ, Jansen-West K, Ash PE, Caulfield T, et al. (2013). Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathologica, 126(6), 829&#x2013;844. 10.1007/s00401-013-1192-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1192-8</ArticleId><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, &amp; Petrucelli L (2009). The role of tau in neurodegeneration. Molecular Neurodegeneration, 4, 13 10.1186/1750-1326-4-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-4-13</ArticleId><ArticleId IdType="pmc">PMC2663562</ArticleId><ArticleId IdType="pubmed">19284597</ArticleId></ArticleIdList></Reference><Reference><Citation>Giorgini F, Guidetti P, Nguyen Q, Bennett SC, &amp; Muchowski PJ (2005). A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease. Nature Genetics, 37(5), 526&#x2013;531. 10.1038/ng1542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1542</ArticleId><ArticleId IdType="pmc">PMC1449881</ArticleId><ArticleId IdType="pubmed">15806102</ArticleId></ArticleIdList></Reference><Reference><Citation>Glover JR, Kowal AS, Schirmer EC, Patino MM, Liu JJ, &amp; Lindquist S (1997). Self-seeded fibers formed by Sup35, the protein determinant of [PSI +], a heritable prionlike factor of S. cerevisiae. Cell, 89(5), 811&#x2013;819. 10.1016/s0092-8674(00)80264-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(00)80264-0</ArticleId><ArticleId IdType="pubmed">9182769</ArticleId></ArticleIdList></Reference><Reference><Citation>Glover JR, &amp; Lindquist S (1998). Hsp104, Hsp70, andHsp40: A novel chaperone system that rescues previously aggregated proteins. Cell, 94(1), 73&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">9674429</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedert M (2018). Tau filaments in neurodegenerative diseases. FEBS Letters, 592(14), 2383&#x2013;2391. 10.1002/1873-3468.13108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13108</ArticleId><ArticleId IdType="pubmed">29790176</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedert M, &amp; Jakes R (1990). Expression of separate isoforms of human tau protein: Correlation with the tau pattern in brain and effects on tubulin polymerization. The EMBO Journal, 9(13), 4225&#x2013;4230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC552204</ArticleId><ArticleId IdType="pubmed">2124967</ArticleId></ArticleIdList></Reference><Reference><Citation>Goehler H, Droge A, Lurz R, Schnoegl S, Chernoff YO, &amp; Wanker EE (2010). Pathogenic polyglutamine tracts are potent inducers of spontaneous Sup35 and Rnq1 amyloidogenesis. PLoS One, 5(3). e9642 10.1371/journal.pone.0009642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009642</ArticleId><ArticleId IdType="pmc">PMC2835767</ArticleId><ArticleId IdType="pubmed">20224794</ArticleId></ArticleIdList></Reference><Reference><Citation>Gokhale KC, Newnam GP, Sherman MY, &amp; Chernoff YO (2005). Modulation of prion-dependent polyglutamine aggregation and toxicity by chaperone proteins in the yeast model. The Journal of Biological Chemistry, 280(24), 22809&#x2013;22818. 10.1074/jbc.M500390200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M500390200</ArticleId><ArticleId IdType="pubmed">15824100</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes RA, Franco C, Da Costa G, Planchon S, Renaut J, Ribeiro RM, et al. (2012). The proteome response to amyloid protein expression in vivo. PLoS One, 7(11), e50123 10.1371/journal.pone.0050123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0050123</ArticleId><ArticleId IdType="pmc">PMC3503758</ArticleId><ArticleId IdType="pubmed">23185553</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong H, Romanova NV, Allen KD, Chandramowlishwaran P, Gokhale K, Newnam GP,et al. (2012). Polyglutamine toxicity is controlled by prion composition and gene dosage in yeast. PLoS Genetics, 8(4). e1002634 10.1371/journal.pgen.1002634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002634</ArticleId><ArticleId IdType="pmc">PMC3334884</ArticleId><ArticleId IdType="pubmed">22536159</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotz J, Chen F, van Dorpe J, &amp; Nitsch RM (2001). Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science, 293(5534), 1491&#x2013;1495. 10.1126/science.1062097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1062097</ArticleId><ArticleId IdType="pubmed">11520988</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, &amp; Greenberg SM (2001). Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Annals of Neurology, 49(6), 697&#x2013;705. 10.1002/ana.1009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.1009</ArticleId><ArticleId IdType="pubmed">11409420</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, &amp; Cashman NR (2014). Prion-like activity of Cu/Zn superoxide dismutase: Implications for amyotrophic lateral sclerosis. Prion, 8(1), 33&#x2013;41. 10.4161/pri.27602.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.27602</ArticleId><ArticleId IdType="pmc">PMC7030911</ArticleId><ArticleId IdType="pubmed">24394345</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Yerbury JJ, Turner BJ, Guest WC, Pokrishevsky E, O&#x2019;Neill MA,et al. (2014). Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proceedings of the National Academy of Sciences of the United States of America, 111(9), 3620&#x2013;3625. 10.1073/pnas.1312245111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1312245111</ArticleId><ArticleId IdType="pmc">PMC3948312</ArticleId><ArticleId IdType="pubmed">24550511</ArticleId></ArticleIdList></Reference><Reference><Citation>Graffmo KS, Forsberg K, Bergh J, Birve A, Zetterstrom P, Andersen PM, et al. (2013). Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis. Human Molecular Genetics, 22(1), 51&#x2013;60. 10.1093/hmg/dds399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds399</ArticleId><ArticleId IdType="pubmed">23026746</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene LE, Zhao X, &amp; Eisenberg E (2018). Curing of [PSI(+)] by Hsp104 overexpression: Clues to solving the puzzle. Prion, 12(1), 9&#x2013;15. 10.1080/19336896.2017.1412911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2017.1412911</ArticleId><ArticleId IdType="pmc">PMC5871032</ArticleId><ArticleId IdType="pubmed">29227184</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffioen G, Duhamel H, Van Damme N, Pellens K, Zabrocki P, Pannecouque C, et al. (2006). A yeast-based model of alpha-synucleinopathy identifies compounds with therapeutic potential. Biochimica et Biophysica Acta, 1762(3), 312&#x2013;318. 10.1016/j.bbadis.2005.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2005.11.009</ArticleId><ArticleId IdType="pubmed">16413174</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber A, Hornburg D, Antonin M, Krahmer N, Collado J, Schaffer M, et al. (2018). Molecular and structural architecture of polyQ aggregates in yeast. Proceedings of the National Academy of Sciences of the United States of America, 115(15), E3446&#x2013;E3453. 10.1073/pnas.1717978115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1717978115</ArticleId><ArticleId IdType="pmc">PMC5899447</ArticleId><ArticleId IdType="pubmed">29581260</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunther MR, Vangilder R, Fang J, &amp; Beattie DS (2004). Expression of a familial amyotrophic lateral sclerosis-associated mutant human superoxide dismutase in yeast leads to decreased mitochondrial electron transport. Archives of Biochemistry and Biophysics, 431(2), 207&#x2013;214. 10.1016/j.abb.2004.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2004.08.009</ArticleId><ArticleId IdType="pubmed">15488469</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Puri A, Singh P, Sonam S, Pandey R, &amp; Sharma D (2018). The yeast stress inducible Ssa Hsp70 reduces alpha-synuclein toxicity by promoting its degradation through autophagy. PLoS Genetics, 14(10), e1007751 10.1371/journal.pgen.1007751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007751</ArticleId><ArticleId IdType="pmc">PMC6226208</ArticleId><ArticleId IdType="pubmed">30376576</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler AR, Donnelly CJ, Periz G, Simko EA, Shaw PG, Kim MS, et al. (2014). C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature, 507(7491), 195&#x2013;200. 10.1038/nature13124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13124</ArticleId><ArticleId IdType="pmc">PMC4046618</ArticleId><ArticleId IdType="pubmed">24598541</ArticleId></ArticleIdList></Reference><Reference><Citation>Hageman J, Rujano MA, van Waarde MA, Kakkar V, Dirks RP, Govorukhina N, et al. (2010). A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation. Molecular Cell, 37(3), 355&#x2013;369. 10.1016/j.molcel.2010.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2010.01.001</ArticleId><ArticleId IdType="pubmed">20159555</ArticleId></ArticleIdList></Reference><Reference><Citation>Halfmann R, Wright JR, Alberti S, Lindquist S, &amp; Rexach M (2012). Prion formation by a yeast GLFG nucleoporin. Prion, 6(4), 391&#x2013;399. 10.4161/pri.20199.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.20199</ArticleId><ArticleId IdType="pmc">PMC3609069</ArticleId><ArticleId IdType="pubmed">22561191</ArticleId></ArticleIdList></Reference><Reference><Citation>Han TW, Kato M, Xie S, Wu LC, Mirzaei H, Pei J, et al. (2012). Cell-free formation of RNA granules: Bound RNAs identify features and components of cellular assemblies. Cell, 149(4), 768&#x2013;779. 10.1016/jxell.2012.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/jxell.2012.04.016</ArticleId><ArticleId IdType="pubmed">22579282</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy J, &amp; Selkoe DJ (2002). The amyloid hypothesis of Alzheimer&#x2019;s disease: Progress and problems on the road to therapeutics. Science, 297(5580), 353&#x2013;356. 10.1126/science.1072994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1072994</ArticleId><ArticleId IdType="pubmed">12130773</ArticleId></ArticleIdList></Reference><Reference><Citation>Harjes P, &amp; Wanker EE (2003). The hunt for huntingtin function: Interaction partners tell many different stories. Trends in Biochemical Sciences, 28(8), 425&#x2013;433. 10.1016/S0968-0004(03)00168-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0968-0004(03)00168-3</ArticleId><ArticleId IdType="pubmed">12932731</ArticleId></ArticleIdList></Reference><Reference><Citation>Helsen CW, &amp; Glover JR (2012). Insight into molecular basis of curing of [PSI+] prion by overexpression of 104-kDa heat shock protein (Hsp104). The Journal of Biological Chemistry, 287(1), 542&#x2013;556. 10.1074/jbc.M111.302869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.302869</ArticleId><ArticleId IdType="pmc">PMC3249108</ArticleId><ArticleId IdType="pubmed">22081611</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilbich C, Kisters-Woike B, Reed J, Masters CL, &amp; Beyreuther K (1992). Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer&#x2019;s disease beta A4 peptides. Journal of Molecular Biology, 228(2), 460&#x2013;473. 10.1016/0022-2836(92)90835-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-2836(92)90835-8</ArticleId><ArticleId IdType="pubmed">1453457</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofweber M, Hutten S, Bourgeois B, Spreitzer E, Niedner-Boblenz A, Schifferer M, et al. (2018). Phase separation of FUS Is suppressed by its nuclear import receptor and arginine methylation. Cell, 173(3), 706&#x2013;719.e713. 10.1016/j.cell.2018.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.004</ArticleId><ArticleId IdType="pubmed">29677514</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes BB, &amp; Diamond MI (2014). Prion-like properties of Tau protein: The importance of extracellular Tau as a therapeutic target. The Journal of Biological Chemistry, 289(29), 19855&#x2013;19861. 10.1074/jbc.R114.549295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R114.549295</ArticleId><ArticleId IdType="pmc">PMC4106306</ArticleId><ArticleId IdType="pubmed">24860099</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes DL, Lancaster AK, Lindquist S,&amp; Halfmann R (2013). Heritable remodeling of yeast multicellularity by an environmentally responsive prion. Cell, 153(1), 153&#x2013;165. 10.1016/j.cell.2013.02.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.02.026</ArticleId><ArticleId IdType="pmc">PMC3759520</ArticleId><ArticleId IdType="pubmed">23540696</ArticleId></ArticleIdList></Reference><Reference><Citation>Hull RL, Westermark GT, Westermark P, &amp; Kahn SE (2004). Islet amyloid: A critical entity in the pathogenesis of type 2 diabetes. The Journal of Clinical Endocrinology and Metabolism, 89(8), 3629&#x2013;3643. 10.1210/jc.2004-0405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2004-0405</ArticleId><ArticleId IdType="pubmed">15292279</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al. (1998). Association of missense and 5&#x2019;-splice-site mutations in tau with the inherited dementia FTDP-17. Nature, 393(6686), 702&#x2013;705. 10.1038/31508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/31508</ArticleId><ArticleId IdType="pubmed">9641683</ArticleId></ArticleIdList></Reference><Reference><Citation>Iglesias V, Conchillo-Sole O, Batlle C, &amp; Ventura S (2019). AMYCO: Evaluation of mutational impact on prion-like proteins aggregation propensity. BMC Bioinformatics, 20(1). 24.10.1186/s12859-019-2601-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-019-2601-3</ArticleId><ArticleId IdType="pmc">PMC6332698</ArticleId><ArticleId IdType="pubmed">30642249</ArticleId></ArticleIdList></Reference><Reference><Citation>Iko Y, Kodama TS, Kasai N, Oyama T, Morita EH, Muto T, et al. (2004). Domain architectures and characterization of an RNA-binding protein, TLS. The Journal of Biological Chemistry, 279(43), 44834&#x2013;44840. 10.1074/jbc.M408552200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M408552200</ArticleId><ArticleId IdType="pubmed">15299008</ArticleId></ArticleIdList></Reference><Reference><Citation>Inge-Vechtomov S, Zhouravleva G, &amp; Philippe M (2003). Eukaryotic release factors (eRFs) history. Biology of the Cell, 95(3&#x2013;4), 195&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pubmed">12867083</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingram EM, &amp; Spillantini MG (2002). Tau gene mutations: Dissecting the pathogenesis of FTDP-17. Trends in Molecular Medicine, 8(12), 555&#x2013;562. 10.1016/s1471-4914(02)02440-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1471-4914(02)02440-1</ArticleId><ArticleId IdType="pubmed">12470988</ArticleId></ArticleIdList></Reference><Reference><Citation>Irvine GB, El-Agnaf OM, Shankar GM, &amp;Walsh DM (2008). Protein aggregation in the brain: The molecular basis for Alzheimer&#x2019;s and Parkinson&#x2019;s diseases. Molecular Medicine, 14(7&#x2013;8), 451&#x2013;464. 10.2119/2007-00100.Irvine.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/2007-00100.Irvine</ArticleId><ArticleId IdType="pmc">PMC2274891</ArticleId><ArticleId IdType="pubmed">18368143</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiguro K, Shiratsuchi A, Sato S, Omori A, Arioka M, Kobayashi S, et al. (1993). Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Letters, 325(3), 167&#x2013;172. 10.1016/0014-5793(93)81066-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(93)81066-9</ArticleId><ArticleId IdType="pubmed">7686508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii T, Kawakami E, Endo K, Misawa H, &amp; Watabe K (2017). Formation and spreading of TDP-43 aggregates in cultured neuronal and glial cells demonstrated by time-lapse imaging. PLoS One, 12(6), e0179375 10.1371/journal.pone.0179375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0179375</ArticleId><ArticleId IdType="pmc">PMC5466347</ArticleId><ArticleId IdType="pubmed">28599005</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwahashi CK, Yasui DH, An HJ, Greco CM, Tassone F, Nannen K, et al. (2006). Protein composition of the intranuclear inclusions of FXTAS. Brain, 129(Pt. 1), 256&#x2013;271. 10.1093/brain/awh650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh650</ArticleId><ArticleId IdType="pubmed">16246864</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackrel ME, DeSantis ME, Martinez BA, Castellano LM, Stewart RM, Caldwell KA, et al. (2014). Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events. Cell, 156(1&#x2013;2), 170&#x2013;182. 10.1016/j.cell.2013.11.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.11.047</ArticleId><ArticleId IdType="pmc">PMC3909490</ArticleId><ArticleId IdType="pubmed">24439375</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackrel ME, &amp; Shorter J (2014). Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins. Disease Models &amp; Mechanisms, 7(10), 1175&#x2013;1184. 10.1242/dmm.016113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.016113</ArticleId><ArticleId IdType="pmc">PMC4174528</ArticleId><ArticleId IdType="pubmed">25062688</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackrel ME, &amp; Shorter J (2015). Engineering enhanced protein disaggregases for neurodegenerative disease. Prion, 9(2), 90&#x2013;109. 10.1080/19336896.2015.1020277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2015.1020277</ArticleId><ArticleId IdType="pmc">PMC4601286</ArticleId><ArticleId IdType="pubmed">25738979</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs KR, Castellano-Gonzalez G, Guillemin GJ, &amp; Lovejoy DB (2017). Major developments in the design of inhibitors along the Kynurenine pathway. Current Medicinal Chemistry, 24(23), 2471&#x2013;2495. 10.2174/0929867324666170502123114.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867324666170502123114</ArticleId><ArticleId IdType="pmc">PMC5748880</ArticleId><ArticleId IdType="pubmed">28464785</ArticleId></ArticleIdList></Reference><Reference><Citation>James BD, Leurgans SE, Hebert LE, Scherr PA, Yaffe K, &amp;Bennett DA (2014). Contribution of Alzheimer disease to mortality in the United States. Neurology, 82(12), 1045&#x2013;1050. 10.1212/WNL.0000000000000240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000240</ArticleId><ArticleId IdType="pmc">PMC3962992</ArticleId><ArticleId IdType="pubmed">24598707</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrett JT, Berger EP, &amp; Lansbury PT Jr. (1993). The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer&#x2019;s disease. Biochemistry, 32(18), 4693&#x2013;4697. 10.1021/bi00069a001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00069a001</ArticleId><ArticleId IdType="pubmed">8490014</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang LL, Zhao J, Yin XF, He WT, Yang H, Che MX, et al. (2016). Two mutations G335D and Q343R within the amyloidogenic core region of TDP-43 influence its aggregation and inclusion formation. Scientific Reports 6, 23928.10.1038/srep23928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23928</ArticleId><ArticleId IdType="pmc">PMC4814915</ArticleId><ArticleId IdType="pubmed">27030292</ArticleId></ArticleIdList></Reference><Reference><Citation>Jicha GA, Bowser R, Kazam IG,&amp; Davies P (1997). Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. Journal of Neuroscience Research, 48(2), 128&#x2013;132. 10.1002/(sici)1097-4547(19970415)48:2&lt;128&#x2237;aid-jnr5&gt;3.0.co;2-e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(sici)1097-4547(19970415)48:2&lt;128&#x2237;aid-jnr5&gt;3.0.co;2-e</ArticleId><ArticleId IdType="pubmed">9130141</ArticleId></ArticleIdList></Reference><Reference><Citation>Joag H, Ghatpande V, Desai M, Sarkar M, Raina A, Shinde M,et al. (2019). Arole of cellular translation regulation associated with toxic Huntingtin protein. Cellular and Molecular Life Sciences. 10.1007/s00018-019-03392-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03392-y</ArticleId><ArticleId IdType="pubmed">31796991</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BS, McCaffery JM, Lindquist S, &amp; Gitler AD (2008). A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proceedings of the National Academy of Sciences of the United States of America, 105(17), 6439&#x2013;6444. 10.1073/pnas.0802082105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0802082105</ArticleId><ArticleId IdType="pmc">PMC2359814</ArticleId><ArticleId IdType="pubmed">18434538</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, &amp; Gitler AD (2009). TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. The Journal of Biological Chemistry, 284(30), 20329&#x2013;20339. 10.1074/jbc.M109.010264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.010264</ArticleId><ArticleId IdType="pmc">PMC2740458</ArticleId><ArticleId IdType="pubmed">19465477</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson SM, Connelly S, Fearns C, Powers ET, &amp; Kelly JW (2012). The transthyretin amyloidoses: From delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug. Journal of Molecular Biology, 421(2&#x2013;3), 185&#x2013;203. 10.1016/j-jmb.2011.12.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j-jmb.2011.12.060</ArticleId><ArticleId IdType="pmc">PMC3350832</ArticleId><ArticleId IdType="pubmed">22244854</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston JA, Ward CL, &amp; Kopito RR (1998). Aggresomes: A cellular response to misfolded proteins. The Journal of Cell Biology, 143(7), 1883&#x2013;1898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2175217</ArticleId><ArticleId IdType="pubmed">9864362</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, et al. (2012). A mutation in APP protects against Alzheimer&#x2019;s disease and age-related cognitive decline. Nature, 488(7409), 96&#x2013;99. 10.1038/nature11283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11283</ArticleId><ArticleId IdType="pubmed">22801501</ArticleId></ArticleIdList></Reference><Reference><Citation>Josse L, Marchante R, Zenthon J, von der Haar T, &amp; Tuite MF (2012). Probing the role of structural features of mouse PrP in yeast by expression as Sup35-PrP fusions. Prion, 6(3), 201&#x2013;210. 10.4161/pri.19214.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.19214</ArticleId><ArticleId IdType="pmc">PMC3399540</ArticleId><ArticleId IdType="pubmed">22449853</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovicic A, Mertens J, Boeynaems S, Bogaert E, Chai N, Yamada SB, et al. (2015). Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nature Neuroscience, 18(9), 1226&#x2013;1229. 10.1038/nn.4085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4085</ArticleId><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju S, Tardiff DF, Han H, Divya K, Zhong Q, Maquat LE, et al. (2011). A yeast model of FUS/TLS-dependent cytotoxicity. PLoS Biology, 9(4). e1001052.10.1371/journal.pbio.1001052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1001052</ArticleId><ArticleId IdType="pmc">PMC3082520</ArticleId><ArticleId IdType="pubmed">21541368</ArticleId></ArticleIdList></Reference><Reference><Citation>Jucker M, &amp; Walker LC (2018). Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases. Nature Neuroscience, 21(10), 1341&#x2013;1349. 10.1038/s41593-018-0238-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0238-6</ArticleId><ArticleId IdType="pmc">PMC6375686</ArticleId><ArticleId IdType="pubmed">30258241</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaganovich D, Kopito R, &amp; Frydman J (2008). Misfolded proteins partition between two distinct quality control compartments. Nature, 454(7208), 1088&#x2013;U1036. 10.1038/nature07195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07195</ArticleId><ArticleId IdType="pmc">PMC2746971</ArticleId><ArticleId IdType="pubmed">18756251</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser CJ, Grotzinger SW, Eckl JM, Papsdorf K, Jordan S, &amp; Richter K (2013). A network of genes connects polyglutamine toxicity to ploidy control in yeast. Nature Communications, 4 1571 10.1038/ncomms2575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2575</ArticleId><ArticleId IdType="pmc">PMC3615466</ArticleId><ArticleId IdType="pubmed">23481379</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakkar V, Mansson C, de Mattos EP, Bergink S, van der Zwaag M, van Waarde M, et al. (2016). The S/T-Rich Motif in the DNAJB6 Chaperone delays polyglutamine aggregation and the onset of disease in a mouse model. Molecular Cell, 62(2), 272&#x2013;283. 10.1016/j.molcel.2016.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.03.017</ArticleId><ArticleId IdType="pubmed">27151442</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalebina TS, Plotnikova TA, Gorkovskii AA, Selyakh IO, Galzitskaya OV, Bezsonov EE, et al. (2008). Amyloid-like properties of Saccharomyces cerevisiae cell wall glucantransferase Bgl2p: Prediction and experimental evidences. Prion, 2(2), 91&#x2013;96. 10.4161/pri.2.2.6645.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.2.2.6645</ArticleId><ArticleId IdType="pmc">PMC2634524</ArticleId><ArticleId IdType="pubmed">19098439</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane MD, Lipinski WJ, Callahan MJ, Bian F, Durham RA, Schwarz RD, et al. (2000). Evidence for seeding of beta-amyloid by intracerebral infusion of Alzheimer brain extracts in beta-amyloid precursor protein-transgenic mice. The Journal of Neuroscience, 20(10), 3606&#x2013;3611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772682</ArticleId><ArticleId IdType="pubmed">10804202</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M, Han TW, Xie S, Shi K, Du X, Wu LC, et al. (2012). Cell-free formation of RNA granules: Low complexity sequence domains form dynamic fibers within hydrogels. Cell, 149(4), 753&#x2013;767. 10.1016/jxell.2012.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/jxell.2012.04.017</ArticleId><ArticleId IdType="pmc">PMC6347373</ArticleId><ArticleId IdType="pubmed">22579281</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman SK, Thomas TL, Del Tredici K, Braak H, &amp; Diamond MI (2017). Characterization of tau prion seeding activity and strains from formaldehyde-fixed tissue. Acta Neuropathologica Communications, 5(1). 41 10.1186/s40478-017-0442-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-017-0442-8</ArticleId><ArticleId IdType="pmc">PMC5461712</ArticleId><ArticleId IdType="pubmed">28587664</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, Diaz Z, et al. (2013). Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature, 495(7442), 467&#x2013;473. 10.1038/nature11922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11922</ArticleId><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Raphael AR, LaDow ES, McGurk L, Weber RA, Trojanowski JQ, et al. (2014). Therapeutic modulation of eIF2alpha phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nature Genetics, 46(2), 152&#x2013;160. 10.1038/ng.2853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2853</ArticleId><ArticleId IdType="pmc">PMC3934366</ArticleId><ArticleId IdType="pubmed">24336168</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YE, Hosp F, Frottin F, Ge H, Mann M, Hayer-Hartl M, et al. (2016). Soluble oligomers of PolyQ-expanded Huntingtin target a multiplicity of key cellular factors. Molecular Cell, 63(6), 951&#x2013;964. https://doi.org/10.1016Zj.molcel.2016.07.022.</Citation><ArticleIdList><ArticleId IdType="pubmed">27570076</ArticleId></ArticleIdList></Reference><Reference><Citation>King CY,&amp; Diaz-Avalos R (2004). Protein-only transmission of three yeast prion strains. Nature, 428(6980), 319&#x2013;323. 10.1038/nature02391nature02391[pii]].</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02391nature02391</ArticleId><ArticleId IdType="pubmed">15029195</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamoto T, Iizuka R, &amp; Tateishi J (1993). An amber mutation of prion protein in Gerstmann-Straussler syndrome with mutant PrP plaques. Biochemical and Biophysical Research Communications, 192(2), 525&#x2013;531. 10.1006/bbrc.1993.1447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1993.1447</ArticleId><ArticleId IdType="pubmed">8097911</ArticleId></ArticleIdList></Reference><Reference><Citation>Kloppel C, Michels C, Zimmer J, Herrmann JM, &amp; Riemer J (2010). In yeast redistribution of Sod1 to the mitochondrial intermembrane space provides protection against respiration derived oxidative stress. Biochemical and Biophysical Research Communications, 403(1), 114&#x2013;119. 10.1016/j.bbrc.2010.10.129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2010.10.129</ArticleId><ArticleId IdType="pubmed">21055392</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowles TP, Vendruscolo M, &amp; Dobson CM (2014). The amyloid state and its association with protein misfolding diseases. Nature Reviews. Molecular Cell Biology, 15(6), 384&#x2013;396. 10.1038/nrm3810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3810</ArticleId><ArticleId IdType="pubmed">24854788</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi A, Hizume M, Teruya K, Mohri S, &amp; Kitamoto T (2009). Heterozygous inhibition in prion infection: The stone fence model. Prion, 3(1), 27&#x2013;30. 10.4161/pri.3.1.8514.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.3.1.8514</ArticleId><ArticleId IdType="pmc">PMC2676740</ArticleId><ArticleId IdType="pubmed">19372732</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi S, Ishiguro K, Omori A, Takamatsu M, Arioka M, Imahori K, et al. (1993). A cdc2-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubule. FEBS Letters, 335(2), 171&#x2013;175. 10.1016/0014-5793(93)80723-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(93)80723-8</ArticleId><ArticleId IdType="pubmed">8253190</ArticleId></ArticleIdList></Reference><Reference><Citation>Kochneva-Pervukhova NV, Alexandrov AI, &amp; Ter-Avanesyan MD (2012). Amyloid-mediated sequestration of essential proteins contributes to mutant huntingtin toxicity in yeast. PLoS One, 7(1). e29832 10.1371/journal.pone.0029832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0029832</ArticleId><ArticleId IdType="pmc">PMC3256205</ArticleId><ArticleId IdType="pubmed">22253794</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopito RR (2000). Aggresomes, inclusion bodies and protein aggregation. Trends in Cell Biology, 10(12), 524&#x2013;530. doi:S0962-8924(00)01852-3 [pii].</Citation><ArticleIdList><ArticleId IdType="pubmed">11121744</ArticleId></ArticleIdList></Reference><Reference><Citation>Krammer C, Kryndushkin D, Suhre MH, Kremmer E, Hofmann A, Pfeifer A, et al. (2009). The yeast Sup35NM domain propagates as a prion in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America, 106(2), 462&#x2013;467. 10.1073/pnas.0811571106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0811571106</ArticleId><ArticleId IdType="pmc">PMC2626725</ArticleId><ArticleId IdType="pubmed">19114662</ArticleId></ArticleIdList></Reference><Reference><Citation>Kritzer JA, Hamamichi S, McCaffery JM, Santagata S, Naumann TA, Caldwell KA, et al. (2009). Rapid selection of cyclic peptides that reduce alpha-synuclein toxicity in yeast and animal models. Nature Chemical Biology, 5(9), 655&#x2013;663. 10.1038/nchembio.193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.193</ArticleId><ArticleId IdType="pmc">PMC2729362</ArticleId><ArticleId IdType="pubmed">19597508</ArticleId></ArticleIdList></Reference><Reference><Citation>Krobitsch S, &amp; Lindquist S (2000). Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proceedings of the National Academy of Sciences of the United States of America, 97(4), 1589&#x2013;1594.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC26479</ArticleId><ArticleId IdType="pubmed">10677504</ArticleId></ArticleIdList></Reference><Reference><Citation>Kryndushkin D, Ihrke G, Piermartiri TC, &amp; Shewmaker F (2012). A yeast model of optineurin proteinopathy reveals a unique aggregation pattern associated with cellular toxicity. Molecular Microbiology, 86(6), 1531&#x2013;1547. 10.1111/mmi.12075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/mmi.12075</ArticleId><ArticleId IdType="pubmed">23078282</ArticleId></ArticleIdList></Reference><Reference><Citation>Kryndushkin D, Wickner RB, &amp; Shewmaker F (2011). FUS/TLS forms cytoplasmic aggregates, inhibits cell growth and interacts with TDP-43 in a yeast model of amyotrophic lateral sclerosis. Protein &amp; Cell, 2(3), 223&#x2013;236. 10.1007/s13238-011-1525-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-011-1525-0</ArticleId><ArticleId IdType="pmc">PMC4875312</ArticleId><ArticleId IdType="pubmed">21452073</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar J, Kline NL, &amp; Masison DC (2018). Human DnaJB6 antiamyloid chaperone protects yeast from polyglutamine toxicity separately from spatial segregation of aggregates. Molecular and Cellular Biology, 38(23), e00437&#x2013;18. 10.1128/MCB.00437-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00437-18</ArticleId><ArticleId IdType="pmc">PMC6234286</ArticleId><ArticleId IdType="pubmed">30224519</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo PH, Chiang CH, Wang YT, Doudeva LG,&amp; Yuan HS (2014). The crystal structure of TDP-43 RRM1-DNA complex reveals the specific recognition for UG- and TG-rich nucleic acids. Nucleic Acids Research, 42(7), 4712&#x2013;4722. 10.1093/nar/gkt1407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt1407</ArticleId><ArticleId IdType="pmc">PMC3985631</ArticleId><ArticleId IdType="pubmed">24464995</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon I, Kato M, Xiang S, Wu L, Theodoropoulos P, Mirzaei H, et al. (2013). Phosphorylation-regulated binding of RNA polymerase II to fibrous polymers of low-complexitydomains. Cell, 155(5), 1049&#x2013;1060.10.1016/j.cell.2013.10.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.10.033</ArticleId><ArticleId IdType="pmc">PMC4010232</ArticleId><ArticleId IdType="pubmed">24267890</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacroute F (1971). Non-Mendelian mutation allowing ureidosuccinic acid uptake in yeast. Journal of Bacteriology, 106(2), 519&#x2013;522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC285125</ArticleId><ArticleId IdType="pubmed">5573734</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, &amp; Cleveland DW (2009). Rethinking ALS: The FUS about TDP-43. Cell, 136(6), 1001&#x2013;1004. 10.1016/jxell.2009.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/jxell.2009.03.006</ArticleId><ArticleId IdType="pmc">PMC3110083</ArticleId><ArticleId IdType="pubmed">19303844</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancaster AK, Bardill JP, True HL, &amp;Masel J (2010). The spontaneous appearance rate of the yeast prion [PSI +] and its implications for the evolution of the evolvability properties of the [PSI+] system. Genetics, 184(2), 393&#x2013;400. 10.1534/genetics.109.110213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.109.110213</ArticleId><ArticleId IdType="pmc">PMC2828720</ArticleId><ArticleId IdType="pubmed">19917766</ArticleId></ArticleIdList></Reference><Reference><Citation>Legname G, &amp; Moda F (2017). The Prion concept and synthetic prions. Progress in Molecular Biology and Translational Science, 150, 147&#x2013;156. 10.1016/bs.pmbts.2017.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.pmbts.2017.06.002</ArticleId><ArticleId IdType="pubmed">28838659</ArticleId></ArticleIdList></Reference><Reference><Citation>Legname G, Virgilio T, Bistaffa E, De Luca CMG, Catania M, Zago P, et al. (2018). Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases. Prion, 12(2), 127&#x2013;137. 10.1080/19336896.2018.1464367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2018.1464367</ArticleId><ArticleId IdType="pmc">PMC6016513</ArticleId><ArticleId IdType="pubmed">29676205</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibiger C, Deisel J, Aufschnaiter A, Ambros S, Tereshchenko M, Verheijen BM, et al. (2018). TDP-43 controls lysosomal pathways thereby determining its own clearance and cytotoxicity. Human Molecular Genetics, 27(9), 1593&#x2013;1607. 10.1093/hmg/ddy066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy066</ArticleId><ArticleId IdType="pubmed">29474575</ArticleId></ArticleIdList></Reference><Reference><Citation>Li A, Dong J, &amp; Harris DA (2004). Cell surface expression of the prion protein in yeast does not alter copper utilization phenotypes. The Journal of Biological Chemistry, 279(28), 29469&#x2013;29477. 10.1074/jbc.M402517200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M402517200</ArticleId><ArticleId IdType="pubmed">15090539</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang J, Clark-Dixon C, Wang S, Flower TR, Williams-Hart T, Zweig R, et al. (2008). Novel suppressors of alpha-synuclein toxicity identified using yeast. Human Molecular Genetics, 17(23), 3784&#x2013;3795. 10.1093/hmg/ddn276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn276</ArticleId><ArticleId IdType="pmc">PMC2581432</ArticleId><ArticleId IdType="pubmed">18772193</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebman SW, &amp; Chernoff YO (2012). Prions in yeast. Genetics, 191(4), 1041&#x2013;1072. 10.1534/genetics.111.137760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.111.137760</ArticleId><ArticleId IdType="pmc">PMC3415993</ArticleId><ArticleId IdType="pubmed">22879407</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindstrom M, &amp; Liu B (2018). Yeast as a model to unravel mechanisms behind FUS toxicity in amyotrophic lateral sclerosis. Frontiers in Molecular Neuroscience, 11, 218 10.3389/fnmol.2018.00218.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00218</ArticleId><ArticleId IdType="pmc">PMC6031741</ArticleId><ArticleId IdType="pubmed">30002616</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipke PN, Klotz SA, Dufrene YF, Jackson DN,&amp; Garcia-Sherman MC (2018). Amyloid-like beta-aggregates as force-sensitive switches in fungal biofilms and infections. Microbiology and Molecular Biology Reviews, 82(1), e00035&#x2013;17. 10.1128/MMBR.00035-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00035-17</ArticleId><ArticleId IdType="pmc">PMC5813885</ArticleId><ArticleId IdType="pubmed">29187516</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, Zhao N, Fu Y, Wang N, Linares C, Tsai CW, et al. (2017). ApoE4 accelerates early seeding of amyloid pathology. Neuron, 96(5), 1024&#x2013;1032.e1023. 10.1016/j.neuron.2017.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.11.013</ArticleId><ArticleId IdType="pmc">PMC5948105</ArticleId><ArticleId IdType="pubmed">29216449</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenz H, Windl O, &amp; Kretzschmar HA (2002). Cellular phenotyping of secretory and nuclear prion proteins associated with inherited prion diseases. The Journal of Biological Chemistry, 277(10), 8508&#x2013;8516. 10.1074/jbc.M110197200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110197200</ArticleId><ArticleId IdType="pubmed">11756421</ArticleId></ArticleIdList></Reference><Reference><Citation>Louros NN, Tsiolaki PL, Zompra AA, Pappa EV, Magafa V, Pairas G, et al. (2015). Structural studies and cytotoxicity assays of &#x201c;aggregation-prone&#x201d; IAPP(8&#x2013;16) and its non-amyloidogenic variants suggest its important role in fibrillogenesis and cytotoxicity of human amylin. Biopolymers, 104(3), 196&#x2013;205. 10.1002/bip.22650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bip.22650</ArticleId><ArticleId IdType="pubmed">25913357</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo F, Gui X, Zhou H, Gu J, Li Y, Liu X, et al. (2018). Atomic structures of FUS LC domain segments reveal bases for reversible amyloid fibril formation. Nature Structural &amp; Molecular Biology, 25(4), 341&#x2013;346. 10.1038/s41594-018-0050-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-018-0050-8</ArticleId><ArticleId IdType="pubmed">29610493</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J, &amp; Lindquist S (1999). De novo generation of a PrPSc-like conformation in living cells. Nature Cell Biology, 1(6), 358&#x2013;361. 10.1038/14053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/14053</ArticleId><ArticleId IdType="pubmed">10559963</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, et al. (2007). Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Annals of Neurology, 61(5), 427&#x2013;434. 10.1002/ana.21147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21147</ArticleId><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Macreadie I, Lotfi-Miri M, Mohotti S, Shapira D, Bennett L, &amp; Varghese J (2008). Validation of folate in a convenient yeast assay suited for identification of inhibitors of Alzheimer&#x2019;s amyloid-beta aggregation. Journal of Alzheimer&#x2019;s Disease, 15(3), 391&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pubmed">18997292</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddelein ML, Dos Reis S, Duvezin-Caubet S, Coulary-Salin B, &amp; Saupe SJ (2002). Amyloid aggregates of the HET-s prion protein are infectious. Proceedings of the National Academy of Sciences of the United States of America, 99(11), 7402&#x2013;7407. 10.1073/pnas.072199199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.072199199</ArticleId><ArticleId IdType="pmc">PMC124243</ArticleId><ArticleId IdType="pubmed">12032295</ArticleId></ArticleIdList></Reference><Reference><Citation>Maji SK, Perrin MH, Sawaya MR, Jessberger S, Vadodaria K, Rissman RA, et al. (2009). Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science, 325(5938), 328&#x2013;332. doi:1173155 [pii]. 10.1126/science.1173155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1173155</ArticleId><ArticleId IdType="pmc">PMC2865899</ArticleId><ArticleId IdType="pubmed">19541956</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumdar A, Cesario WC, White-Grindley E, Jiang H, Ren F, Khan MR, et al. (2012). Critical role of amyloid-like oligomers of Drosophila Orb2 in the persistence of memory. Cell, 148(3), 515&#x2013;529. 10.1016/jxell.2012.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/jxell.2012.01.004</ArticleId><ArticleId IdType="pubmed">22284910</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallik S, Yang W, Norstrom EM, &amp; Mastrianni JA (2010). Live cell fluorescence resonance energy transfer predicts an altered molecular association of heterologous PrPSc with PrPC. The Journal of Biological Chemistry, 285(12), 8967&#x2013;8975. 10.1074/jbc.M109.058107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.058107</ArticleId><ArticleId IdType="pmc">PMC2838318</ArticleId><ArticleId IdType="pubmed">20086009</ArticleId></ArticleIdList></Reference><Reference><Citation>Manogaran AL, Fajardo VM, Reid RJ, Rothstein R, &amp; Liebman SW (2010). Most, but not all, yeast strains in the deletion library contain the [PIN(+)] prion. Yeast, 27(3), 159&#x2013;166. 10.1002/yea.1740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/yea.1740</ArticleId><ArticleId IdType="pmc">PMC3717406</ArticleId><ArticleId IdType="pubmed">20014044</ArticleId></ArticleIdList></Reference><Reference><Citation>Manson JC, Jamieson E, Baybutt H, Tuzi NL, Barron R, McConnell I, et al. (1999). A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. The EMBO Journal, 18(23), 6855&#x2013;6864. 10.1093/emboj/18.23.6855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/18.23.6855</ArticleId><ArticleId IdType="pmc">PMC1171748</ArticleId><ArticleId IdType="pubmed">10581259</ArticleId></ArticleIdList></Reference><Reference><Citation>March ZM, King OD, &amp; Shorter J (2016). Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease. Brain Research, 1647, 9&#x2013;18. 10.1016/j.brainres.2016.02.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.02.037</ArticleId><ArticleId IdType="pmc">PMC5003744</ArticleId><ArticleId IdType="pubmed">26996412</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathur V, Taneja V, Sun Y, &amp; Liebman SW (2010). Analyzing the birth and propagation of two distinct prions, [PSI+] and [Het-s](y), in yeast. Molecular Biology of the Cell, 21(9), 1449&#x2013;1461. doi:E09&#x2013;11-0927 [pii]. 10.1091/mbc.E09-11-0927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E09-11-0927</ArticleId><ArticleId IdType="pmc">PMC2861605</ArticleId><ArticleId IdType="pubmed">20219972</ArticleId></ArticleIdList></Reference><Reference><Citation>Matias PM, Baek SH, Bandeiras TM, Dutta A, Houry WA, Llorca O, et al. (2015). The AAA+ proteins Pontin and Reptin enter adult age: From understanding their basic biology to the identification of selective inhibitors. Frontiers in Molecular Biosciences, 2, 17 10.3389/fmolb.2015.00017.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2015.00017</ArticleId><ArticleId IdType="pmc">PMC4428354</ArticleId><ArticleId IdType="pubmed">25988184</ArticleId></ArticleIdList></Reference><Reference><Citation>Matlack KE, Tardiff DF, Narayan P, Hamamichi S, Caldwell KA, Caldwell GA, et al. (2014). Clioquinol promotes the degradation of metal-dependent amyloid-beta (Abeta) oligomers to restore endocytosis and ameliorate Abeta toxicity. Proceedings of the National Academy of Sciences of the United States of America, 111(11), 4013&#x2013;4018. 10.1073/pnas.1402228111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1402228111</ArticleId><ArticleId IdType="pmc">PMC3964050</ArticleId><ArticleId IdType="pubmed">24591589</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurer-Stroh S, Debulpaep M, Kuemmerer N, Lopez de la Paz M, Martins IC, Reumers J, et al. (2010). Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nature Methods, 7(3), 237&#x2013;242. 10.1038/nmeth.1432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1432</ArticleId><ArticleId IdType="pubmed">20154676</ArticleId></ArticleIdList></Reference><Reference><Citation>Maziuk BF, Apicco DJ, Cruz AL, Jiang L, Ash PEA, da Rocha EL, et al. (2018). RNA binding proteins co-localize with small tau inclusions in tauopathy. Acta Neuropathologica Communications, 6(1), 71 10.1186/s40478-018-0574-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0574-5</ArticleId><ArticleId IdType="pmc">PMC6069705</ArticleId><ArticleId IdType="pubmed">30068389</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlary L, Plotkin SS, Yerbury JJ, &amp; Cashman NR (2019). Prion-like propagation of protein misfolding and aggregation in amyotrophic lateral sclerosis. Frontiers in Molecular Neuroscience, 12, 262 10.3389/fnmol.2019.00262.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00262</ArticleId><ArticleId IdType="pmc">PMC6838634</ArticleId><ArticleId IdType="pubmed">31736708</ArticleId></ArticleIdList></Reference><Reference><Citation>McGlinchey RP, Kryndushkin D, &amp; Wickner RB (2011). Suicidal [PSI+] is a lethal yeast prion. Proceedings of the National Academy of Sciences of the United States of America, 108(13), 5337&#x2013;5341. 10.1073/pnas.1102762108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1102762108</ArticleId><ArticleId IdType="pmc">PMC3069153</ArticleId><ArticleId IdType="pubmed">21402947</ArticleId></ArticleIdList></Reference><Reference><Citation>Mead S, Whitfield J, Poulter M, Shah P, Uphill J, Beck J, et al. (2008). Genetic susceptibility, evolution and the kuru epidemic. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 363(1510), 3741&#x2013;3746. 10.1098/rstb.2008.0087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2008.0087</ArticleId><ArticleId IdType="pmc">PMC2576515</ArticleId><ArticleId IdType="pubmed">18849290</ArticleId></ArticleIdList></Reference><Reference><Citation>Meriin AB, Zhang X, Alexandrov IM, Salnikova AB, Ter-Avanesian MD, Chernoff YO, et al. (2007). Endocytosis machinery is involved in aggregation of proteins with expanded polyglutamine domains. The FASEB Journal, 21(8), 1915&#x2013;1925. 10.1096/fj.06-6878com.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.06-6878com</ArticleId><ArticleId IdType="pubmed">17341688</ArticleId></ArticleIdList></Reference><Reference><Citation>Meriin AB, Zhang X, He X, Newnam GP, Chernoff YO, &amp; Sherman MY (2002). Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1. The Journal of Cell Biology, 157(6), 997&#x2013;1004. 10.1083/jcb.200112104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200112104</ArticleId><ArticleId IdType="pmc">PMC2174031</ArticleId><ArticleId IdType="pubmed">12058016</ArticleId></ArticleIdList></Reference><Reference><Citation>Meriin AB, Zhang X, Miliaras NB, Kazantsev A, Chernoff YO, McCaffery JM, et al. (2003). Aggregation of expanded polyglutamine domain in yeast leads to defects in endocytosis. Molecular and Cellular Biology, 23(21), 7554&#x2013;7565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC207640</ArticleId><ArticleId IdType="pubmed">14560003</ArticleId></ArticleIdList></Reference><Reference><Citation>Metrick MA 2nd, do Carmo Ferreira N, Saijo E, Hughson AG, Kraus A, Orru C, et al. (2019). Million-fold sensitivity enhancement in proteopathic seed amplification assays for biospecimens by Hofmeister ion comparisons. Proceedings of the National Academy of Sciences of the United States of America, 116(46), 23029&#x2013;23039. 10.1073/pnas.1909322116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1909322116</ArticleId><ArticleId IdType="pmc">PMC6859373</ArticleId><ArticleId IdType="pubmed">31641070</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelitsch MD, &amp; Weissman JS (2000). A census of glutamine/asparagine-rich regions: Implications for their conserved function and the prediction of novel prions. Proceedings of the National Academy of Sciences of the United States of America, 97(22), 11910&#x2013;11915. 10.1073/pnas.97.22.1191097/22/11910tii].</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.97.22.1191097/22/11910tii</ArticleId><ArticleId IdType="pmc">PMC17268</ArticleId><ArticleId IdType="pubmed">11050225</ArticleId></ArticleIdList></Reference><Reference><Citation>Mietelska-Porowska A, Wasik U, Goras M, Filipek A, &amp; Niewiadomska G (2014). Tau protein modifications and interactions: Their role in function and dysfunction. International Journal of Molecular Sciences, 15(3), 4671&#x2013;4713. 10.3390/ijms15034671.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms15034671</ArticleId><ArticleId IdType="pmc">PMC3975420</ArticleId><ArticleId IdType="pubmed">24646911</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitkevich OV, Kochneva-Pervukhova NV, Surina ER, Benevolensky SV, Kushnirov VV, &amp; Ter-Avanesyan MD (2012). DNA aptamers detecting generic amyloid epitopes. Prion, 6(4), 400&#x2013;406. 10.4161/pri.20678.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.20678</ArticleId><ArticleId IdType="pmc">PMC3609070</ArticleId><ArticleId IdType="pubmed">22874671</ArticleId></ArticleIdList></Reference><Reference><Citation>Mompean M, Romano V, Pantoja-Uceda D, Stuani C, Baralle FE, Buratti E, et al. (2016). The TDP-43 N-terminal domain structure at high resolution. The FEBS Journal, 283(7), 1242&#x2013;1260. 10.1111/febs.13651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.13651</ArticleId><ArticleId IdType="pubmed">26756435</ArticleId></ArticleIdList></Reference><Reference><Citation>Monahan Z, Ryan VH, Janke AM, Burke KA, Rhoads SN, Zerze GH, et al. (2017). Phosphorylation of the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity. The EMBO Journal, 36(20), 2951&#x2013;2967. 10.15252/embj.201696394.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201696394</ArticleId><ArticleId IdType="pmc">PMC5641905</ArticleId><ArticleId IdType="pubmed">28790177</ArticleId></ArticleIdList></Reference><Reference><Citation>Monahan ZT, Rhoads SN, Yee DS, &amp; Shewmaker FP (2018). Yeast models of prion-like proteins that cause amyotrophic lateral sclerosis reveal pathogenic mechanisms. Frontiers in Molecular Neuroscience, 11, 453 10.3389/fnmol.2018.00453.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00453</ArticleId><ArticleId IdType="pmc">PMC6297178</ArticleId><ArticleId IdType="pubmed">30618605</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Arzberger T, Grasser FA, Gijselinck I, May S, Rentzsch K, et al. (2013). Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathologica, 126(6), 881&#x2013;893. 10.1007/s00401-013-1189-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1189-3</ArticleId><ArticleId IdType="pubmed">24132570</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto A, Irie K, Murakami K, Masuda Y, Ohigashi H, Nagao M, et al. (2004). Analysis of the secondary structure of beta-amyloid (Abeta42) fibrils by systematic proline replacement. The Journal of Biological Chemistry, 279(50), 52781&#x2013;52788. 10.1074/jbc.M406262200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M406262200</ArticleId><ArticleId IdType="pubmed">15459202</ArticleId></ArticleIdList></Reference><Reference><Citation>Muchowski PJ, Schaffar G, Sittler A, Wanker EE, Hayer-Hartl MK,&amp; Hartl FU (2000). Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. Proceedings of the National Academy of Sciences of the United States of America, 97(14), 7841&#x2013;7846. 10.1073/pnas.140202897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.140202897</ArticleId><ArticleId IdType="pmc">PMC16632</ArticleId><ArticleId IdType="pubmed">10859365</ArticleId></ArticleIdList></Reference><Reference><Citation>Munch C, &amp; Bertolotti A (2011). Self-propagation and transmission of misfolded mutant SOD1: Prion or prion-like phenomenon? Cell Cycle, 10(11), 1711 10.4161/cc.10.11.15560.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.10.11.15560</ArticleId><ArticleId IdType="pubmed">21471733</ArticleId></ArticleIdList></Reference><Reference><Citation>Munch C, O&#x2019;Brien J, &amp; Bertolotti A (2011). Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proceedings of the National Academy of Sciences of the United States of America, 108(9), 3548&#x2013;3553. 10.1073/pnas.1017275108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1017275108</ArticleId><ArticleId IdType="pmc">PMC3048161</ArticleId><ArticleId IdType="pubmed">21321227</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T, Qamar S, Lin JQ, Schierle GS, Rees E, Miyashita A, et al. (2015). ALS/FTD mutation-induced phase transition of FUS liquid droplets and reversible hydrogels into irreversible hydrogels impairs RNP granule function. Neuron, 88(4), 678&#x2013;690. 10.1016/j.neuron.2015.10.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.030</ArticleId><ArticleId IdType="pmc">PMC4660210</ArticleId><ArticleId IdType="pubmed">26526393</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray DT, Kato M, Lin Y, Thurber KR, Hung I, McKnight SL, et al. (2017). Structure of FUS protein fibrils and its relevance to self-assembly and phase separation of low-complexity domains. Cell, 171(3), 615&#x2013;627.e616. https://doi.org/10.1016Zj.cell.2017.08.048.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5650524</ArticleId><ArticleId IdType="pubmed">28942918</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamichi S, Yamanaka K, Suzuki M, Watanabe T, &amp; Kagiwada S (2011). Human VAPA and the yeast VAP Scs2p with an altered proline distribution can phenocopy amyotrophic lateral sclerosis-associated VAPB(P56S). Biochemical and Biophysical Research Communications, 404(2), 605&#x2013;609. 10.1016/j.bbrc.2010.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2010.12.011</ArticleId><ArticleId IdType="pubmed">21144830</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam WH, &amp; Choi YP (2019). In vitro generation of tau aggregates conformationally distinct from parent tau seeds of Alzheimer&#x2019;s brain. Prion, 13(1), 1&#x2013;12. 10.1080/19336896.2018.1545524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2018.1545524</ArticleId><ArticleId IdType="pmc">PMC6422395</ArticleId><ArticleId IdType="pubmed">30422056</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan A, Meriin A, Andrews JO, Spille JH, Sherman MY, &amp; Cisse II (2019). A first order phase transition mechanism underlies protein aggregation in mammalian cells. eLife, 8, e39695 10.7554/eLife.39695.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.39695</ArticleId><ArticleId IdType="pmc">PMC6361590</ArticleId><ArticleId IdType="pubmed">30716021</ArticleId></ArticleIdList></Reference><Reference><Citation>Naslund J, Schierhorn A, Hellman U, Lannfelt L, Roses AD, Tjernberg LO, et al. (1994). Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. Proceedings of the National Academy of Sciences of the United States of America, 91(18), 8378&#x2013;8382. 10.1073/pnas.91.18.8378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.18.8378</ArticleId><ArticleId IdType="pmc">PMC44609</ArticleId><ArticleId IdType="pubmed">8078890</ArticleId></ArticleIdList></Reference><Reference><Citation>Ness F, Cox BS, Wongwigkarn J, Naeimi WR, &amp; Tuite MF (2017). Overexpression of the molecular chaperone Hsp104 in Saccharomyces cerevisiae results in the malpartition of [PSI+ ] propagons. Molecular Microbiology, 104(1), 125&#x2013;143. 10.1111/mmi.13617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/mmi.13617</ArticleId><ArticleId IdType="pubmed">28073182</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314(5796), 130&#x2013;133. 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevzglyadova OV, Mikhailova EV, Artemov AV, Ozerova YE, Ivanova PA, Golomidov IM, et al. (2018). Yeast red pigment modifies cloned human alpha-synuclein pathogenesis in Parkinson disease models in Saccharomyces cerevisiae and Drosophila melanogaster. Neurochemistry International, 120, 172&#x2013;181. 10.1016/j.neuint.2018.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2018.08.002</ArticleId><ArticleId IdType="pubmed">30099122</ArticleId></ArticleIdList></Reference><Reference><Citation>Newby GA, Kiriakov S, Hallacli E, Kayatekin C, Tsvetkov P, Mancuso CP, et al. (2017). A genetic tool to track protein aggregates and control prion inheritance. Cell, 171(4), 966&#x2013;979.e18. 10.1016/j.cell.2017.09.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.09.041</ArticleId><ArticleId IdType="pmc">PMC5675731</ArticleId><ArticleId IdType="pubmed">29056345</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen P, Oumata N, Soubigou F, Evrard J, Desban N, Lemoine P, et al. (2014). Evaluation of the antiprion activity of 6-aminophenanthridines and related heterocycles. European Journal of Medicinal Chemistry, 82, 363&#x2013;371. 10.1016/j.ejmech.2014.05.083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2014.05.083</ArticleId><ArticleId IdType="pubmed">24927056</ArticleId></ArticleIdList></Reference><Reference><Citation>Nizhnikov AA, Alexandrov AI, Ryzhova TA, Mitkevich OV, Dergalev AA, Ter-Avanesyan MD, et al. (2014). Proteomic screening for amyloid proteins. PLoS One, 9(12), e116003 10.1371/journal.pone.0116003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0116003</ArticleId><ArticleId IdType="pmc">PMC4280166</ArticleId><ArticleId IdType="pubmed">25549323</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T, &amp; Hasegawa M (2018). TDP-43 Prions. Cold Spring Harbor Perspectives in Medicine, 8(3), a024463 10.1101/cshperspect.a024463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024463</ArticleId><ArticleId IdType="pmc">PMC5830907</ArticleId><ArticleId IdType="pubmed">28108532</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T, Kametani F, Arai T, Akiyama H, &amp; Hasegawa M (2009). Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Human Molecular Genetics, 18(18), 3353&#x2013;3364. 10.1093/hmg/ddp275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp275</ArticleId><ArticleId IdType="pubmed">19515851</ArticleId></ArticleIdList></Reference><Reference><Citation>Nystrom S, &amp; Hammarstrom P (2014). Is the prevalent human prion protein 129M/V mutation a living fossil from a paleolithic panzootic superprion pandemic? Prion, 8(1), 2&#x2013;10. 10.4161/pri.27601.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.27601</ArticleId><ArticleId IdType="pmc">PMC7030913</ArticleId><ArticleId IdType="pubmed">24398570</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell CW, Waldispuhl J, Lis M, Halfmann R, Devadas S, Lindquist S, et al. (2011). A method for probing the mutational landscape of amyloid structure. Bioinformatics, 27(13), i34&#x2013;i42. 10.1093/bioinformatics/btr238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btr238</ArticleId><ArticleId IdType="pmc">PMC3117379</ArticleId><ArticleId IdType="pubmed">21685090</ArticleId></ArticleIdList></Reference><Reference><Citation>Osherovich LZ, Cox BS, Tuite MF, &amp; Weissman JS (2004). Dissection and design of yeast prions. PLoS Biology, 2(4). E86.10.1371/journal.pbio.0020086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0020086</ArticleId><ArticleId IdType="pmc">PMC374241</ArticleId><ArticleId IdType="pubmed">15045026</ArticleId></ArticleIdList></Reference><Reference><Citation>Osherovich LZ, &amp; Weissman JS (2001). Multiple Gln/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI(+)] prion. Cell, 106(2), 183&#x2013;194. doi:S0092-8674(01)00440-8 [pii].</Citation><ArticleIdList><ArticleId IdType="pubmed">11511346</ArticleId></ArticleIdList></Reference><Reference><Citation>Otzen D, &amp; Riek R (2019). Functional amyloids. Cold Spring Harbor Perspectives in Biology, 11(12), a033860 10.1101/cshperspect.a033860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a033860</ArticleId><ArticleId IdType="pmc">PMC6886451</ArticleId><ArticleId IdType="pubmed">31088827</ArticleId></ArticleIdList></Reference><Reference><Citation>Outeiro TF, &amp; Lindquist S (2003). Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science, 302(5651), 1772&#x2013;1775. 10.1126/science.1090439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1090439</ArticleId><ArticleId IdType="pmc">PMC1780172</ArticleId><ArticleId IdType="pubmed">14657500</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallares I, de Groot NS, Iglesias V, Sant&#x2019;Anna R, Biosca A, Fernandez-Busquets X, et al. (2018). Discovering putative prion-like proteins in Plasmodium falciparum: A computational and experimental analysis. Frontiers in Microbiology, 9, 1737 10.3389/fmicb.2018.01737.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.01737</ArticleId><ArticleId IdType="pmc">PMC6090025</ArticleId><ArticleId IdType="pubmed">30131778</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Park SK, Watanabe N, Hashimoto T, Iwatsubo T, Shelkovnikova TA, et al. (2019). Calcium-responsive transactivator (CREST) toxicity is rescued by loss of PBP1/ATXN2 function in a novel yeast proteinopathy model and in transgenic flies. PLoS Genetics, 15(8), e1008308 10.1371/journal.pgen.1008308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1008308</ArticleId><ArticleId IdType="pmc">PMC6699716</ArticleId><ArticleId IdType="pubmed">31390360</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SH, Kukushkin Y, Gupta R, Chen T, Konagai A, Hipp MS, et al. (2013). PolyQ proteins interfere with nuclear degradation of cytosolic proteins by sequestering the Sis1p chaperone. Cell, 154(1), 134&#x2013;145. 10.1016/jxell.2013.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/jxell.2013.06.003</ArticleId><ArticleId IdType="pubmed">23791384</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SK, Arslan F, Kanneganti V, Barmada SJ, Purushothaman P, Verma SC, et al. (2018). Overexpression of a conserved HSP40 chaperone reduces toxicity of several neurodegenerative disease proteins. Prion, 12(1), 16&#x2013;22. 10.1080/19336896.2017.1423185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2017.1423185</ArticleId><ArticleId IdType="pmc">PMC5871033</ArticleId><ArticleId IdType="pubmed">29308690</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SK, Hong JY, Arslan F, Kanneganti V, Patel B, Tietsort A, et al. (2017). Overexpression of the essential Sis1 chaperone reduces TDP-43 effects on toxicity and proteolysis. PLoS Genetics, 13(5). e1006805 10.1371/journal.pgen.1006805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1006805</ArticleId><ArticleId IdType="pmc">PMC5460882</ArticleId><ArticleId IdType="pubmed">28531192</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SK, Park S, &amp; Liebman SW (2019). Respiration enhances TDP-43 toxicity, but TDP-43 retains some toxicity in the absence of respiration. Journal of Molecular Biology, 431(10), 2050&#x2013;2059. 10.1016/j-jmb.2019.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j-jmb.2019.03.014</ArticleId><ArticleId IdType="pmc">PMC6502655</ArticleId><ArticleId IdType="pubmed">30905713</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SK, Pegan SD, Mesecar AD, Jungbauer LM, LaDu MJ, &amp; Liebman SW (2011). Development and validation of a yeast high-throughput screen for inhibitors of Abeta(4)(2) oligomerization. Disease Models &amp; Mechanisms, 4(6), 822&#x2013;831. 10.1242/dmm.007963.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.007963</ArticleId><ArticleId IdType="pmc">PMC3209651</ArticleId><ArticleId IdType="pubmed">21810907</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SK, Ratia K, Ba M, Valencik M, &amp; Liebman SW (2016). Inhibition of Abeta42 oligomerization in yeast by a PICALM ortholog and certain FDA approved drugs. Microbial Cell, 3(2), 53&#x2013;64. 10.15698/mic2016.02.476.</Citation><ArticleIdList><ArticleId IdType="doi">10.15698/mic2016.02.476</ArticleId><ArticleId IdType="pmc">PMC5349104</ArticleId><ArticleId IdType="pubmed">28357335</ArticleId></ArticleIdList></Reference><Reference><Citation>Park YN, Zhao X, Yim YI, Todor H, Ellerbrock R, Reidy M, et al. (2014). Hsp104 overexpression cures Saccharomyces cerevisiae [PSI+] by causing dissolution of the prion seeds. Eukaryotic Cell, 13(5), 635&#x2013;647. 10.1128/EC.00300-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/EC.00300-13</ArticleId><ArticleId IdType="pmc">PMC4060481</ArticleId><ArticleId IdType="pubmed">24632242</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, Lee HO, Jawerth L, Maharana S, Jahnel M, Hein MY, et al. (2015). A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell, 162(5), 1066&#x2013;1077. 10.1016/j.cell.2015.07.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.047</ArticleId><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel BK, Gavin-Smyth J, &amp; Liebman SW (2009). The yeast global transcriptional co-repressor protein Cyc8 can propagate as a prion. Nature Cell Biology, 11(3), 344&#x2013;349. doi:ncb1843 [pii]. 10.1038/ncb1843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1843</ArticleId><ArticleId IdType="pmc">PMC2667906</ArticleId><ArticleId IdType="pubmed">19219034</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul KR, Molliex A, Cascarina S, Boncella AE, Taylor JP, &amp; Ross ED (2017). Effects of mutations on the aggregation propensity of the human prion-like protein hnRNPA2B1. Molecular and Cellular Biology, 37(8), e00652&#x2013;16. 10.1128/MCB.00652-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00652-16</ArticleId><ArticleId IdType="pmc">PMC5376634</ArticleId><ArticleId IdType="pubmed">28137911</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrier V, Kaneko K, Safar J, Vergara J, Tremblay P, DeArmond SJ, et al. (2002). Dominant-negative inhibition of prion replication in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America, 99(20), 13079&#x2013;13084. 10.1073/pnas.182425299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.182425299</ArticleId><ArticleId IdType="pmc">PMC130589</ArticleId><ArticleId IdType="pubmed">12271119</ArticleId></ArticleIdList></Reference><Reference><Citation>Perutz MF, Johnson T, Suzuki M, &amp; Finch JT (1994). Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases. Proceedings of the National Academy of Sciences of the United States of America, 91(12), 5355&#x2013;5358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC43993</ArticleId><ArticleId IdType="pubmed">8202492</ArticleId></ArticleIdList></Reference><Reference><Citation>Peskett TR, Rau F, O&#x2019;Driscoll J, Patani R, Lowe AR, &amp; Saibil HR (2018). A liquid to solid phase transition underlying pathological Huntingtin Exon1 aggregation. Molecular Cell, 70(4), 588&#x2013;601.e586. 10.1016/j.molcel.2018.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.04.007</ArticleId><ArticleId IdType="pmc">PMC5971205</ArticleId><ArticleId IdType="pubmed">29754822</ArticleId></ArticleIdList></Reference><Reference><Citation>Piotrowski JS, &amp; Tardiff DF (2019). From yeast to humans: Leveraging new approaches in yeast to accelerate discovery of therapeutic targets for synucleinopathies. Methods in Molecular Biology, 2049, 419&#x2013;444. 10.1007/978-1-4939-9736-7_24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-9736-7_24</ArticleId><ArticleId IdType="pubmed">31602625</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokrishevsky E, Grad LI, &amp; Cashman NR (2016). TDP-43 or FUS-induced misfolded human wild-type SOD1 can propagate intercellularly in a prion-like fashion. Scientific Reports, 6, 22155 10.1038/srep22155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep22155</ArticleId><ArticleId IdType="pmc">PMC4772009</ArticleId><ArticleId IdType="pubmed">26926802</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokrishevsky E, Hong RH, Mackenzie IR, &amp; Cashman NR (2017). Spinal cord homogenates from SOD1 familial amyotrophic lateral sclerosis induce SOD1 aggregation in living cells. PLoS One, 12(9). e0184384 10.1371/journal.pone.0184384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0184384</ArticleId><ArticleId IdType="pmc">PMC5587256</ArticleId><ArticleId IdType="pubmed">28877271</ArticleId></ArticleIdList></Reference><Reference><Citation>Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, et al. (1998). Tau is a candidate gene for chromosome 17 frontotemporal dementia. Annals of Neurology, 43(6), 815&#x2013;825. 10.1002/ana.410430617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410430617</ArticleId><ArticleId IdType="pubmed">9629852</ArticleId></ArticleIdList></Reference><Reference><Citation>Popova B, Kleinknecht A, &amp; Braus GH (2015). Posttranslational modifications and clearing of alpha-synuclein aggregates in yeast. Biomolecules, 5(2), 617&#x2013;634. 10.3390/biom5020617.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom5020617</ArticleId><ArticleId IdType="pmc">PMC4496687</ArticleId><ArticleId IdType="pubmed">25915624</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabakaran R, Goel D, Kumar S, &amp; Gromiha MM (2017). Aggregation prone regions in human proteome: Insights from large-scale data analyses. Proteins, 85(6), 1099&#x2013;1118. 10.1002/prot.25276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.25276</ArticleId><ArticleId IdType="pubmed">28257595</ArticleId></ArticleIdList></Reference><Reference><Citation>Prusiner SB (1998). Prions. Proceedings of the National Academy of Sciences of the United States of America, 95(23), 13363&#x2013;13383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC33918</ArticleId><ArticleId IdType="pubmed">9811807</ArticleId></ArticleIdList></Reference><Reference><Citation>Prusiner SB (2012). Cell biology. A unifying role for prions in neurodegenerative diseases. Science, 336(6088), 1511&#x2013;1513. 10.1126/science.1222951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1222951</ArticleId><ArticleId IdType="pmc">PMC3942086</ArticleId><ArticleId IdType="pubmed">22723400</ArticleId></ArticleIdList></Reference><Reference><Citation>Prusiner SB (2013). Biology and genetics of prions causing neurodegeneration. Annual Review of Genetics, 47, 601&#x2013;623. 10.1146/annurev-genet-110711-155524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genet-110711-155524</ArticleId><ArticleId IdType="pmc">PMC4010318</ArticleId><ArticleId IdType="pubmed">24274755</ArticleId></ArticleIdList></Reference><Reference><Citation>Prusiner SB, Woerman AL, Mordes DA, Watts JC, Rampersaud R, Berry DB, et al. (2015). Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proceedings of the National Academy of Sciences of the United States of America, 112(38), E5308&#x2013;E5317. 10.1073/pnas.1514475112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1514475112</ArticleId><ArticleId IdType="pmc">PMC4586853</ArticleId><ArticleId IdType="pubmed">26324905</ArticleId></ArticleIdList></Reference><Reference><Citation>Qamar S, Wang G, Randle SJ, Ruggeri FS, Varela JA, Lin JQ, et al. (2018). FUS phase separation is modulated by a molecular chaperone and methylation of arginine cation-pi interactions. Cell, 173(3), 720&#x2013;734.e715. 10.1016/j.cell.2018.03.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.056</ArticleId><ArticleId IdType="pmc">PMC5927716</ArticleId><ArticleId IdType="pubmed">29677515</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin H, Lim LZ, Wei Y, &amp; Song J (2014). TDP-43 N terminus encodes a novel ubiquitin-like fold and its unfolded form in equilibrium that can be shifted by binding to ssDNA. Proceedings of the National Academy of Sciences of the United States of America, 111(52), 18619&#x2013;18624. 10.1073/pnas.1413994112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1413994112</ArticleId><ArticleId IdType="pmc">PMC4284588</ArticleId><ArticleId IdType="pubmed">25503365</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabizadeh S, Gralla EB, Borchelt DR, Gwinn R, Valentine JS, Sisodia S, et al. (1995). Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: Studies in yeast and neural cells. Proceedings of the National Academy of Sciences of the United States of America, 92(7), 3024&#x2013;3028. 10.1073/pnas.92.7.3024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.92.7.3024</ArticleId><ArticleId IdType="pmc">PMC42351</ArticleId><ArticleId IdType="pubmed">7708768</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajasekhar K, Suresh SN, Manjithaya R, &amp; Govindaraju T (2015). Rationally designed peptidomimetic modulators of abeta toxicity in Alzheimer&#x2019;s disease. Scientific Reports, 5, 8139 10.1038/srep08139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep08139</ArticleId><ArticleId IdType="pmc">PMC4311240</ArticleId><ArticleId IdType="pubmed">25633824</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratovitski T, Gucek M, Jiang H, Chighladze E, Waldron E, D&#x2019;Ambola J, et al. (2009). Mutant huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells. The Journal of Biological Chemistry, 284(16), 10855&#x2013;10867. 10.1074/jbc.M804813200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M804813200</ArticleId><ArticleId IdType="pmc">PMC2667772</ArticleId><ArticleId IdType="pubmed">19204007</ArticleId></ArticleIdList></Reference><Reference><Citation>Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek DF, et al. (1996). Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genetics, 13(1), 43&#x2013;47. 10.1038/ng0596-43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0596-43</ArticleId><ArticleId IdType="pubmed">8673102</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy G, Straub JE, &amp; Thirumalai D (2009). Influence of preformed Asp23-Lys28 salt bridge on the conformational fluctuations of monomers and dimers of Abeta peptides with implications for rates of fibril formation. The Journal of Physical Chemistry B, 113(4), 1162&#x2013;1172. 10.1021/jp808914c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jp808914c</ArticleId><ArticleId IdType="pmc">PMC3098509</ArticleId><ArticleId IdType="pubmed">19125574</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren PH, Lauckner JE, Kachirskaia I, Heuser JE, Melki R, &amp;Kopito RR (2009). Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nature Cell Biology, 11(2), 219&#x2013;225. 10.1038/ncb1830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1830</ArticleId><ArticleId IdType="pmc">PMC2757079</ArticleId><ArticleId IdType="pubmed">19151706</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chio A,&amp; Traynor BJ (2014). State of play in amyotrophic lateral sclerosis genetics. Nature Neuroscience, 17(1), 17&#x2013;23. 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhoads SN, Monahan ZT, Yee DS, Leung AY, Newcombe CG, O&#x2019;Meally RN, et al. (2018). The prionlike domain of FUS is multiphosphorylated following DNA damage without altering nuclear localization. Molecular Biology of the Cell, 29(15), 1786&#x2013;1797. 10.1091/mbc.E17-12-0735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E17-12-0735</ArticleId><ArticleId IdType="pmc">PMC6085830</ArticleId><ArticleId IdType="pubmed">29897835</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard P, Feng S, &amp; Manley JL (2013). A SUMO-dependent interaction between Senataxin and the exosome, disrupted in the neurodegenerative disease AOA2, targets the exosome to sites of transcription-induced DNA damage. Genes &amp; Development, 27(20), 2227&#x2013;2232. 10.1101/gad.224923.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.224923.113</ArticleId><ArticleId IdType="pmc">PMC3814643</ArticleId><ArticleId IdType="pubmed">24105744</ArticleId></ArticleIdList></Reference><Reference><Citation>Riedel M, Goldbaum O, &amp; Richter-Landsberg C (2009). Alpha-synuclein promotes the recruitment of tau to protein inclusions in oligodendroglial cells: Effects of oxidative and proteolytic stress. Journal of Molecular Neuroscience, 39(1&#x2013;2), 226&#x2013;234. 10.1007/s12031-009-9190-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-009-9190-y</ArticleId><ArticleId IdType="pubmed">19266322</ArticleId></ArticleIdList></Reference><Reference><Citation>Rikhvanov EG, Romanova NV, &amp; Chernoff YO (2007). Chaperone effects on prion and nonprion aggregates. Prion, 1(4), 217&#x2013;222. doi:5058 [pii].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2634534</ArticleId><ArticleId IdType="pubmed">19164915</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripaud L, Chumakova V, Antonin M, Hastie AR, Pinkert S, Korner R, et al. (2014). Overexpression of Q-rich prion-like proteins suppresses polyQ cytotoxicity and alters the polyQ interactome. Proceedings of the National Academy of Sciences of the United States of America, 111(51), 18219&#x2013;18224. 10.1073/pnas.1421313111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1421313111</ArticleId><ArticleId IdType="pmc">PMC4280636</ArticleId><ArticleId IdType="pubmed">25489109</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers RC, Kumita JR, Tartaglia GG, Dedmon MM, Pawar A, Vendruscolo M, et al. (2008). Molecular determinants of the aggregation behavior of alpha- and beta-synuclein. Protein Science, 17(5), 887&#x2013;898. 10.1110/ps.073181508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1110/ps.073181508</ArticleId><ArticleId IdType="pmc">PMC2327276</ArticleId><ArticleId IdType="pubmed">18436957</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson JL, Geser F, Stieber A, Umoh M, Kwong LK, Van Deerlin VM, et al. (2013). TDP-43 skeins show properties of amyloid in a subset of ALS cases. Acta Neuropathologica, 125(1), 121&#x2013;131. 10.1007/s00401-012-1055-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1055-8</ArticleId><ArticleId IdType="pmc">PMC3536927</ArticleId><ArticleId IdType="pubmed">23124365</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi M, Baiardi S, &amp; Parchi P (2019). Understanding prion strains: Evidence from studies of the disease forms affecting humans. Viruses, 11(4), 309 10.3390/v11040309.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11040309</ArticleId><ArticleId IdType="pmc">PMC6520670</ArticleId><ArticleId IdType="pubmed">30934971</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubel AA, Ryzhova TA, Antonets KS, Chernoff YO, &amp; Galkin A (2013). Identification of PrP sequences essential for the interaction between the PrP polymers and Abeta peptide in a yeast-based assay. Prion, 7(6), 469&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201615</ArticleId><ArticleId IdType="pubmed">24152606</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubel AA, Saifitdinova AF, Lada AG, Nizhnikov AA, Inge-Vechtomov SG, &amp; Galkin AP (2008). Yeast chaperone Hsp 104 controls gene expression at the posttran-scriptional level. Molecular Biology, 42(1), 110&#x2013;116. 10.1134/S0026893308010160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0026893308010160</ArticleId></ArticleIdList></Reference><Reference><Citation>Satyal SH, Schmidt E, Kitagawa K, Sondheimer N, Lindquist S, Kramer JM, et al. (2000). Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proceedings of the National Academy of Sciences of the United States of America, 97(11), 5750&#x2013;5755. 10.1073/pnas.100107297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.100107297</ArticleId><ArticleId IdType="pmc">PMC18505</ArticleId><ArticleId IdType="pubmed">10811890</ArticleId></ArticleIdList></Reference><Reference><Citation>Saupe SJ (2011). The [Het-s] prion of Podospora anserina and its role in heterokaryon incompatibility. Seminars in Cell &amp; Developmental Biology, 22(5), 460&#x2013;468. 10.1016/j.semcdb.2011.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2011.02.019</ArticleId><ArticleId IdType="pubmed">21334447</ArticleId></ArticleIdList></Reference><Reference><Citation>Saupe SJ, Jarosz DF, &amp; True HL (2016). Amyloid prions in fungi. Microbiology Spectrum, 4(6), UNSP FUNK-0029-2016. 10.1128/microbiolspec.FUNK-0029-2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/microbiolspec.FUNK-0029-2016</ArticleId><ArticleId IdType="pubmed">28087950</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz JC, Wang X, Podell ER, &amp; Cech TR (2013). RNA seeds higher-order assembly of FUS protein. Cell Reports, 5(4), 918&#x2013;925. https://doi.org/10.1016Zj.celrep.2013.11.017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3925748</ArticleId><ArticleId IdType="pubmed">24268778</ArticleId></ArticleIdList></Reference><Reference><Citation>Selivanova OM, Glyakina AV, Gorbunova EY, Mustaeva LG, Suvorina MY, Grigorashvili EI, et al. (2016). Structural model of amyloid fibrils for amyloidogenic peptide from Bgl2p-glucantransferase of S. cerevisiae cell wall and its modifying analog. New morphology of amyloid fibrils. Biochimica et Biophysica Acta, 1864(11), 1489&#x2013;1499. 10.1016/j.bbapap.2016.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2016.08.002</ArticleId><ArticleId IdType="pubmed">27500912</ArticleId></ArticleIdList></Reference><Reference><Citation>Sergeeva AV, Sopova JV, Belashova TA, Siniukova VA, Chirinskaite AV, Galkin AP, et al. (2019). Amyloid properties of the yeast cell wall protein Toh1 and its interaction with prion proteins Rnq1 and Sup35. Prion, 13(1), 21&#x2013;32. 10.1080/19336896.2018.1558763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2018.1558763</ArticleId><ArticleId IdType="pmc">PMC6422396</ArticleId><ArticleId IdType="pubmed">30558459</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio TR (2018). [PIN+]ing down the mechanism of prion appearance. FEMS Yeast Research, 18(3), foy026 10.1093/femsyr/foy026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/femsyr/foy026</ArticleId><ArticleId IdType="pmc">PMC5889010</ArticleId><ArticleId IdType="pubmed">29718197</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio TR, Cashikar AG, Moslehi JJ, Kowal AS, &amp; Lindquist SL (1999). Yeast prion [psi +] and its determinant, Sup35p. Methods in Enzymology, 309, 649&#x2013;673.</Citation><ArticleIdList><ArticleId IdType="pubmed">10507053</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpionov GV, Alexandrov AI, Antonenko YN, &amp; Ter-Avanesyan MD (2015). A protein polymerization cascade mediates toxicity of non-pathological human huntingtin in yeast. Scientific Reports, 5, 18407 10.1038/srep18407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep18407</ArticleId><ArticleId IdType="pmc">PMC4682096</ArticleId><ArticleId IdType="pubmed">26673834</ArticleId></ArticleIdList></Reference><Reference><Citation>Sethi R, Tripathi N, Pallapati AR, Gaikar A, Bharatam PV,&amp; Roy I (2018). Does N-terminal huntingtin function as a &#x2018;holdase&#x2019; for inhibiting cellular protein aggregation? The FEBS Journal, 285(10), 1791&#x2013;1811. 10.1111/febs.14457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.14457</ArticleId><ArticleId IdType="pubmed">29630769</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao J, &amp; Diamond MI (2007). Polyglutamine diseases: Emerging concepts in pathogenesis and therapy. Human Molecular Genetics, 16 Spec No. 2, R115&#x2013;R123. 10.1093/hmg/ddm213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm213</ArticleId><ArticleId IdType="pubmed">17911155</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Lyashchenko AK, Lu L, Nasrabady SE, Elmaleh M, Mendelsohn M, et al. (2016). ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nature Communications, 7, 10465 10.1038/ncomms10465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10465</ArticleId><ArticleId IdType="pmc">PMC4742863</ArticleId><ArticleId IdType="pubmed">26842965</ArticleId></ArticleIdList></Reference><Reference><Citation>Shattuck JE, Waechter AC, &amp; Ross ED (2017). The effects of glutamine/asparagine content on aggregation and heterologous prion induction by yeast prion-like domains. Prion, 11(4), 249&#x2013;264. 10.1080/19336896.2017.1344806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2017.1344806</ArticleId><ArticleId IdType="pmc">PMC5553303</ArticleId><ArticleId IdType="pubmed">28665753</ArticleId></ArticleIdList></Reference><Reference><Citation>Si K, Choi YB, White-Grindley E, Majumdar A, &amp; Kandel ER (2010). Aplysia CPEB can form prion-like multimers in sensory neurons that contribute to long-term facilitation. Cell, 140(3), 421&#x2013;435. 10.1016/j.cell.2010.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.01.008</ArticleId><ArticleId IdType="pubmed">20144764</ArticleId></ArticleIdList></Reference><Reference><Citation>Si K, Lindquist S, &amp; Kandel ER (2003). A neuronal isoform of the aplysia CPEB has prion-like properties. Cell, 115(7), 879&#x2013;891.</Citation><ArticleIdList><ArticleId IdType="pubmed">14697205</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva JL, Cino EA, Soares IN, Ferreira VF, &amp;AP de Oliveira G (2018). Targeting the prion-like aggregation of mutant p53 to combat cancer. Accounts of Chemical Research, 51(1), 181&#x2013;190. 10.1021/acs.accounts.7b00473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.accounts.7b00473</ArticleId><ArticleId IdType="pubmed">29260852</ArticleId></ArticleIdList></Reference><Reference><Citation>Smethurst P, Newcombe J, Troakes C, Simone R, Chen YR, Patani R, et al. (2016). In vitro prion-like behaviour of TDP-43 in ALS. Neurobiology of Disease, 96, 236&#x2013;247. 10.1016/j.nbd.2016.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.08.007</ArticleId><ArticleId IdType="pmc">PMC5113659</ArticleId><ArticleId IdType="pubmed">27590623</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofola OA, Jin P, Qin Y, Duan R, Liu H, de Haro M, et al. (2007). RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS. Neuron, 55(4), 565&#x2013;571. https://doi.Org/10.1016/j.neuron.2007.07.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2007.07.021</ArticleId><ArticleId IdType="pmc">PMC2215388</ArticleId><ArticleId IdType="pubmed">17698010</ArticleId></ArticleIdList></Reference><Reference><Citation>Sondheimer N, Lopez N, Craig EA, &amp; Lindquist S (2001). The role of Sis1 in the maintenance of the [RNQ+] prion. The EMBO Journal, 20(10), 2435&#x2013;2442. 10.1093/emboj/20.10.2435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/20.10.2435</ArticleId><ArticleId IdType="pmc">PMC125465</ArticleId><ArticleId IdType="pubmed">11350932</ArticleId></ArticleIdList></Reference><Reference><Citation>Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, et al. (2010). The Alzheimer&#x2019;s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One, 5(3). e9505 10.1371/journal.pone.0009505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009505</ArticleId><ArticleId IdType="pmc">PMC2831066</ArticleId><ArticleId IdType="pubmed">20209079</ArticleId></ArticleIdList></Reference><Reference><Citation>Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, &amp; Ghetti B (1998). Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proceedings of the National Academy of Sciences of the United States of America, 95(13), 7737&#x2013;7741. 10.1073/pnas.95.13.7737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.13.7737</ArticleId><ArticleId IdType="pmc">PMC22742</ArticleId><ArticleId IdType="pubmed">9636220</ArticleId></ArticleIdList></Reference><Reference><Citation>Spires-Jones TL, Stoothoff WH, de Calignon A, Jones PB, &amp; Hyman BT (2009). Tau pathophysiology in neurodegeneration: A tangled issue. Trends in Neurosciences, 32(3), 150&#x2013;159. 10.1016/j.tins.2008.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2008.11.007</ArticleId><ArticleId IdType="pubmed">19162340</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, et al. (2008). TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science, 319(5870), 1668&#x2013;1672. 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl N, Borchelt DR, Hsiao K, &amp; Prusiner SB (1987). Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell, 51(2), 229&#x2013;240. 10.1016/0092-8674(87)90150-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(87)90150-4</ArticleId><ArticleId IdType="pubmed">2444340</ArticleId></ArticleIdList></Reference><Reference><Citation>Steele JW, Lachenmayer ML, Ju S, Stock A, Liken J, Kim SH, et al. (2013). Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer&#x2019;s mouse model. Molecular Psychiatry, 18(8), 889&#x2013;897. 10.1038/mp.2012.106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2012.106</ArticleId><ArticleId IdType="pmc">PMC3625697</ArticleId><ArticleId IdType="pubmed">22850627</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturtz LA, Diekert K, Jensen LT, Lill R, &amp; Culotta VC (2001). A fraction of yeast Cu,Zn-superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria. A physiological role for SOD1 in guarding against mitochondrial oxidative damage. The Journal of Biological Chemistry, 276(41), 38084&#x2013;38089. 10.1074/jbc.M105296200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M105296200</ArticleId><ArticleId IdType="pubmed">11500508</ArticleId></ArticleIdList></Reference><Reference><Citation>Su LJ, Auluck PK, Outeiro TF, Yeger-Lotem E, Kritzer JA, Tardiff DF, et al. (2010). Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson&#x2019;s disease models. Disease Models &amp; Mechanisms, 3(3&#x2013;4), 194&#x2013;208. 10.1242/dmm.004267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.004267</ArticleId><ArticleId IdType="pmc">PMC2869493</ArticleId><ArticleId IdType="pubmed">20038714</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z, Diaz Z, Fang X, Hart MP, Chesi A, Shorter J, et al. (2011). Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biology, 9(4). e1000614 10.1371/journal.pbio.1000614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1000614</ArticleId><ArticleId IdType="pmc">PMC3082519</ArticleId><ArticleId IdType="pubmed">21541367</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki G, Shimazu N, &amp; Tanaka M (2012). A yeast prion, Mod5, promotes acquired drug resistance and cell survival under environmental stress. Science, 336(6079), 355&#x2013;359. 10.1126/science.1219491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1219491</ArticleId><ArticleId IdType="pubmed">22517861</ArticleId></ArticleIdList></Reference><Reference><Citation>Takata T, Kimura Y, Ohnuma Y, Kawawaki J, Kakiyama Y, Tanaka K, et al. (2012). Rescue of growth defects of yeast cdc48 mutants by pathogenic IBMPFD-VCPs. Journal of Structural Biology, 179(2), 93&#x2013;103. 10.1016/j.jsb.2012.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2012.06.005</ArticleId><ArticleId IdType="pubmed">22728077</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka M, Chien P, Naber N, Cooke R, &amp; Weissman JS (2004). Conformational variations in an infectious protein determine prion strain differences. Nature, 428(6980), 323&#x2013;328. 10.1038/nature02392nature02392[pii].</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02392nature02392</ArticleId><ArticleId IdType="pubmed">15029196</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka M, Collins SR, Toyama BH, &amp; Weissman JS (2006). The physical basis of how prion conformations determine strain phenotypes. Nature, 442(7102), 585&#x2013;589. 10.1038/nature04922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04922</ArticleId><ArticleId IdType="pubmed">16810177</ArticleId></ArticleIdList></Reference><Reference><Citation>Tardiff DF, Jui NT, Khurana V, Tambe MA, Thompson ML, Chung CY, et al. (2013). Yeast reveal a &#x201c;druggable&#x201d; Rsp5/Nedd4 network that ameliorates alpha-synuclein toxicity in neurons. Science, 342(6161), 979&#x2013;983. 10.1126/science.1245321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1245321</ArticleId><ArticleId IdType="pmc">PMC3993916</ArticleId><ArticleId IdType="pubmed">24158909</ArticleId></ArticleIdList></Reference><Reference><Citation>Tardiff DF, &amp; Lindquist S (2013). Phenotypic screens for compounds that target the cellular pathologies underlying Parkinson&#x2019;s disease. Drug Discovery Today: Technologies, 10(1), e121&#x2013;e128. https://doi.org/10.10167j.ddtec.2012.02.003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3641658</ArticleId><ArticleId IdType="pubmed">24050240</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarutani A, &amp; Hasegawa M (2019). Prion-like propagation of alpha-synuclein in neurodegenerative diseases. Progress in Molecular Biology and Translational Science, 168, 323&#x2013;348. 10.1016/bs.pmbts.2019.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.pmbts.2019.07.005</ArticleId><ArticleId IdType="pubmed">31699325</ArticleId></ArticleIdList></Reference><Reference><Citation>Teyssou E, Vandenberghe N, Moigneu C, Boillee S, Couratier P, Meininger V, et al. (2014). Genetic analysis of SS18L1 in French amyotrophic lateral sclerosis. Neurobiology of Aging, 35(5). 10.1016/j.neurobiolaging.2013.11.023. 1213.e1219&#x2013;1213. e1212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.11.023</ArticleId><ArticleId IdType="pubmed">24360741</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Meng L, &amp; Zhang Z (2019). What is strain in neurodegenerative diseases? Cellular and Molecular Life Sciences. 10.1007/s00018-019-03298-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03298-9</ArticleId><ArticleId IdType="pubmed">31531680</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolar M, Abushakra S, &amp; Sabbagh M (2019). The path forward in Alzheimer&#x2019;s disease therapeutics: Reevaluating the amyloid cascade hypothesis. Alzheimer&#x2019;s &amp; Dementia, pii: S1552-5260(19)35450-0. 10.1016/j.jalz.2019.09.075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2019.09.075</ArticleId><ArticleId IdType="pubmed">31706733</ArticleId></ArticleIdList></Reference><Reference><Citation>Toombs JA, Petri M, Paul KR, Kan GY, Ben-Hur A, &amp; Ross ED (2012). De novo design of synthetic prion domains. Proceedings of the National Academy of Sciences of the United States of America, 109(17), 6519&#x2013;6524. 10.1073/pnas.1119366109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1119366109</ArticleId><ArticleId IdType="pmc">PMC3340034</ArticleId><ArticleId IdType="pubmed">22474356</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyama BH, Kelly MJ, Gross JD, &amp; Weissman JS (2007). The structural basis of yeast prion strain variants. Nature, 449(7159), 233&#x2013;237. 10.1038/nature06108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06108</ArticleId><ArticleId IdType="pubmed">17767153</ArticleId></ArticleIdList></Reference><Reference><Citation>Tradewell ML, Yu Z, Tibshirani M, Boulanger MC, Durham HD,&amp; Richard S (2012). Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations. Human Molecular Genetics, 21(1), 136&#x2013;149. 10.1093/hmg/ddr448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr448</ArticleId><ArticleId IdType="pubmed">21965298</ArticleId></ArticleIdList></Reference><Reference><Citation>Treusch S, &amp; Lindquist S (2012). An intrinsically disordered yeast prion arrests the cell cycle by sequestering a spindle pole body component. The Journal of Cell Biology, 197(3), 369&#x2013;379. 10.1083/jcb.201108146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201108146</ArticleId><ArticleId IdType="pmc">PMC3341155</ArticleId><ArticleId IdType="pubmed">22529103</ArticleId></ArticleIdList></Reference><Reference><Citation>Udan M, &amp; Baloh RH (2011). Implications of the prion-related Q/N domains in TDP- 43 and FUS. Prion, 5(1), 1&#x2013;5. 10.4161/pri.5.1.14265.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.5.1.14265</ArticleId><ArticleId IdType="pmc">PMC3037998</ArticleId><ArticleId IdType="pubmed">21135580</ArticleId></ArticleIdList></Reference><Reference><Citation>Uddin MS, Kabir MT, Al Mamun A, Abdel-Daim MM, Barreto GE, &amp; Ashraf GM (2019). APOE and Alzheimer&#x2019;s disease: Evidence mounts that targeting APOE4 may combat Alzheimer&#x2019;s pathogenesis. Molecular Neurobiology, 56(4), 2450&#x2013;2465. 10.1007/s12035-018-1237-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1237-z</ArticleId><ArticleId IdType="pubmed">30032423</ArticleId></ArticleIdList></Reference><Reference><Citation>Uversky VN (2017). Looking at the recent advances in understanding alpha-synuclein and its aggregation through the proteoform prism. F1000Res, 6, 525 10.12688/f1000research.10536.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.10536.1</ArticleId><ArticleId IdType="pmc">PMC5399969</ArticleId><ArticleId IdType="pubmed">28491292</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Nostrand WE, Melchor JP, Cho HS, Greenberg SM, &amp; Rebeck GW (2001). Pathogenic effects of D23N Iowa mutant amyloid beta -protein. The Journal of Biological Chemistry, 276(35), 32860&#x2013;32866. 10.1074/jbc.M104135200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M104135200</ArticleId><ArticleId IdType="pubmed">11441013</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, et al. (2009). Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science, 323(5918), 1208&#x2013;1211. 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandebroek T, Terwel D, Vanhelmont T, Gysemans M, Van Haesendonck C, Engelborghs Y, et al. (2006). Microtubule binding and clustering of human Tau-4R and Tau-P301L proteins isolated from yeast deficient in orthologues of glycogen synthase kinase-3beta or cdk5. The Journal of Biological Chemistry, 281(35), 25388&#x2013;25397. 10.1074/jbc.M602792200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M602792200</ArticleId><ArticleId IdType="pubmed">16818492</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandebroek T, Vanhelmont T, Terwel D, Borghgraef P, Lemaire K, Snauwaert J, et al. (2005). Identification and isolation of a hyperphosphorylated, conformationally changed intermediate of human protein tau expressed in yeast. Biochemistry, 44(34), 11466&#x2013;11475. 10.1021/bi0506775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi0506775</ArticleId><ArticleId IdType="pubmed">16114883</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderweyde T, Apicco DJ, Youmans-Kidder K, Ash PEA, Cook C, Lummertz da Rocha E, et al. (2016). Interaction of tau with the RNA-binding protein TIA1 regulates tau pathophysiology and toxicity. Cell Reports, 15(7), 1455&#x2013;1466. 10.1016/j.celrep.2016.04.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.04.045</ArticleId><ArticleId IdType="pmc">PMC5325702</ArticleId><ArticleId IdType="pubmed">27160897</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanhelmont T, Vandebroek T, De Vos A, Terwel D, Lemaire K, Anandhakumar J, et al. (2010). Serine-409 phosphorylation and oxidative damage define aggregation of human protein tau in yeast. FEMS Yeast Research, 10(8), 992&#x2013;1005. 10.1111/j.1567-1364.2010.00662.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1567-1364.2010.00662.x</ArticleId><ArticleId IdType="pubmed">20662935</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma M, Girdhar A, Patel B, Ganguly NK, Kukreti R, &amp; Taneja V (2018). Q-Rich yeast prion [PSI(+)] accelerates aggregation of transthyretin, a Non-Q-Rich human protein. Frontiers in Molecular Neuroscience, 11, 75 10.3389/fnmol.2018.00075.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00075</ArticleId><ArticleId IdType="pmc">PMC5859028</ArticleId><ArticleId IdType="pubmed">29593496</ArticleId></ArticleIdList></Reference><Reference><Citation>Voisset C, Blondel M, Jones GW, Friocourt G, Stahl G, Chedin S, et al. (2017). The double life of the ribosome: When its protein folding activity supports prion propagation. Prion, 11(2), 89&#x2013;97. 10.1080/19336896.2017.1303587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2017.1303587</ArticleId><ArticleId IdType="pmc">PMC5399909</ArticleId><ArticleId IdType="pubmed">28362551</ArticleId></ArticleIdList></Reference><Reference><Citation>von der Haar T, Josse L, Wright P, Zenthon J, &amp; Tuite MF (2007). Development of a novel yeast cell-based system for studying the aggregation of Alzheimer&#x2019;s disease-associated Abeta peptides in vivo. Neurodegenerative Diseases, 4(2&#x2013;3), 136&#x2013;147. 10.1159/000101838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000101838</ArticleId><ArticleId IdType="pubmed">17596708</ArticleId></ArticleIdList></Reference><Reference><Citation>Vorberg IM (2019). All the same? The secret life of prion strains within their target cells. Viruses, 11(4), E334 10.3390/v11040334.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11040334</ArticleId><ArticleId IdType="pmc">PMC6520713</ArticleId><ArticleId IdType="pubmed">30970585</ArticleId></ArticleIdList></Reference><Reference><Citation>Waelter S, Scherzinger E, Hasenbank R, Nordhoff E, Lurz R, Goehler H, et al. (2001). The huntingtin interacting protein HIP1 is a clathrin and alpha-adaptin-binding protein involved in receptor-mediated endocytosis. Human Molecular Genetics, 10(17), 1807&#x2013;1817. 10.1093/hmg/10.17.1807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/10.17.1807</ArticleId><ArticleId IdType="pubmed">11532990</ArticleId></ArticleIdList></Reference><Reference><Citation>Waite AJ, Baumer D, East S, Neal J, Morris HR, Ansorge O, et al. (2014). Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiology of Aging, 35(7). 10.1016/j.neurobiolaging.2014.01.016.1779.e1775-1779.e1713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.01.016.1779.e1775-1779.e1713</ArticleId><ArticleId IdType="pmc">PMC3988882</ArticleId><ArticleId IdType="pubmed">24559645</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker LC (2018). Prion-like mechanisms in Alzheimer disease. Handbook of Clinical Neurology, 153, 303&#x2013;319. 10.1016/B978-0-444-63945-5.00016-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63945-5.00016-7</ArticleId><ArticleId IdType="pmc">PMC6375694</ArticleId><ArticleId IdType="pubmed">29887142</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker LC, Lynn DG, &amp; Chernoff YO (2018). A standard model of Alzheimer&#x2019;s disease? Prion, 12(5&#x2013;6), 261&#x2013;265. 10.1080/19336896.2018.1525256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2018.1525256</ArticleId><ArticleId IdType="pmc">PMC6277193</ArticleId><ArticleId IdType="pubmed">30220236</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, &amp; Cho YK (2019). Yeast surface display of full-length human microtubule-associated protein tau. Biotechnology Progress, e2920 10.1002/btpr.2920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/btpr.2920</ArticleId><ArticleId IdType="pubmed">31581367</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Meriin AB, Costello CE, &amp; Sherman MY (2007). Characterization of proteins associated with polyglutamine aggregates: A novel approach towards isolation of aggregates from protein conformation disorders. Prion, 1(2), 128&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2634453</ArticleId><ArticleId IdType="pubmed">19164926</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Meriin AB, Zaarur N, Romanova NV, Chernoff YO, Costello CE, et al. (2009). Abnormal proteins can form aggresome in yeast: Aggresome-targeting signals and components of the machinery. The FASEB Journal, 23(2), 451&#x2013;463. doi: fj.08-117614 [pii]. 10.1096/fj.08-117614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.08-117614</ArticleId><ArticleId IdType="pmc">PMC2630789</ArticleId><ArticleId IdType="pubmed">18854435</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts JC, Giles K, Oehler A, Middleton L, Dexter DT, Gentleman SM, et al. (2013). Transmission of multiple system atrophy prions to transgenic mice. Proceedings of the National Academy of Sciences of the United States of America, 110(48), 19555&#x2013;19560. 10.1073/pnas.1318268110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1318268110</ArticleId><ArticleId IdType="pmc">PMC3845125</ArticleId><ArticleId IdType="pubmed">24218576</ArticleId></ArticleIdList></Reference><Reference><Citation>Weaver CL, Espinoza M, Kress Y, &amp; Davies P (2000). Conformational change as one of the earliest alterations of tau in Alzheimer&#x2019;s disease. Neurobiology of Aging, 21(5), 719&#x2013;727. 10.1016/s0197-4580(00)00157-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0197-4580(00)00157-3</ArticleId><ArticleId IdType="pubmed">11016541</ArticleId></ArticleIdList></Reference><Reference><Citation>Weissmann C, &amp; Flechsig E (2003). PrP knock-out and PrP transgenic mice in prion research. British Medical Bulletin, 66, 43&#x2013;60. 10.1093/bmb/66.1.43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/66.1.43</ArticleId><ArticleId IdType="pubmed">14522848</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen Y, Planel E, Herman M, Figueroa HY, Wang L, Liu L, et al. (2008). Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing. The Journal of Neuroscience, 28(10), 2624&#x2013;2632. 10.1523/JNEUROSCI.5245-07.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5245-07.2008</ArticleId><ArticleId IdType="pmc">PMC6671193</ArticleId><ArticleId IdType="pubmed">18322105</ArticleId></ArticleIdList></Reference><Reference><Citation>Westermark P, Engstrom U, Johnson KH, Westermark GT, &amp;Betsholtz C (1990). Islet amyloid polypeptide: Pinpointing amino acid residues linked to amyloid fibril formation. Proceedings of the National Academy of Sciences of the United States of America, 87(13), 5036&#x2013;5040. 10.1073/pnas.87.13.5036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.87.13.5036</ArticleId><ArticleId IdType="pmc">PMC54256</ArticleId><ArticleId IdType="pubmed">2195544</ArticleId></ArticleIdList></Reference><Reference><Citation>Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, et al. (2004). Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington&#x2019;s disease age of onset. Proceedings of the National Academy of Sciences of the United States of America, 101(10), 3498&#x2013;3503. 10.1073/pnas.0308679101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0308679101</ArticleId><ArticleId IdType="pmc">PMC373491</ArticleId><ArticleId IdType="pubmed">14993615</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickner RB (1994). [URE3] as an altered URE2 protein: Evidence for a prion analog in Saccharomyces cerevisiae. Science, 264(5158), 566&#x2013;569.</Citation><ArticleIdList><ArticleId IdType="pubmed">7909170</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickner RB (2016). Yeast and fungal prions. Cold Spring Harbor Perspectives in Biology, 8(9), a023531 10.1101/cshperspect.a023531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a023531</ArticleId><ArticleId IdType="pmc">PMC5008071</ArticleId><ArticleId IdType="pubmed">27481532</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickner RB (2019). Anti-prion systems in yeast. The Journal of Biological Chemistry, 294(5), 1729&#x2013;1738. 10.1074/jbc.TM118.004168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.TM118.004168</ArticleId><ArticleId IdType="pmc">PMC6364766</ArticleId><ArticleId IdType="pubmed">30710020</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickner RB, Edskes HK, Bateman DA, Kelly AC, Gorkovskiy A, Dayani Y, et al. (2014). Amyloid diseases of yeast: Prions are proteins acting as genes. Essays in Biochemistry, 56, 193&#x2013;205. 10.1042/bse0560193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bse0560193</ArticleId><ArticleId IdType="pubmed">25131596</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickner RB, Edskes HK, Gorkovskiy A, Bezsonov EE, &amp; Stroobant EE (2016). Yeast and fungal prions: Amyloid-handling systems, amyloid structure, and prion biology. Advances in Genetics, 93, 191&#x2013;236. 10.1016/bs.adgen.2015.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.adgen.2015.12.003</ArticleId><ArticleId IdType="pubmed">26915272</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickner RB, Edskes HK, Kryndushkin D, McGlinchey R, Bateman D, &amp;Kelly A (2011). Prion diseases of yeast: Amyloid structure and biology. Seminars in Cell &amp; Developmental Biology, 22(5), 469&#x2013;475. 10.1016/j.semcdb.2011.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2011.02.021</ArticleId><ArticleId IdType="pmc">PMC3117979</ArticleId><ArticleId IdType="pubmed">21345375</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild EJ, &amp; Tabrizi SJ (2014). Targets for future clinical trials in Huntington&#x2019;s disease: What&#x2019;s in the pipeline? Movement Disorders, 29(11), 1434&#x2013;1445. 10.1002/mds.26007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26007</ArticleId><ArticleId IdType="pmc">PMC4265300</ArticleId><ArticleId IdType="pubmed">25155142</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams AD, Portelius E, Kheterpal I, Guo JT, Cook KD, Xu Y, et al. (2004). Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis. Journal of Molecular Biology, 335(3), 833&#x2013;842. 10.1016/j-jmb.2003.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j-jmb.2003.11.008</ArticleId><ArticleId IdType="pubmed">14687578</ArticleId></ArticleIdList></Reference><Reference><Citation>Willingham S, Outeiro TF, DeVit MJ, Lindquist SL, &amp; Muchowski PJ (2003). Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science, 302(5651), 1769&#x2013;1772. 10.1126/science.1090389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1090389</ArticleId><ArticleId IdType="pubmed">14657499</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson CJ, Bommarius AS, Champion JA, Chernoff YO, Lynn DG, Paravastu AK, et al. (2018). Biomolecular assemblies: Moving from observation to predictive design. Chemical Reviews, 118(24), 11519&#x2013;11574. 10.1021/acs.chemrev.8b00038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrev.8b00038</ArticleId><ArticleId IdType="pmc">PMC6650774</ArticleId><ArticleId IdType="pubmed">30281290</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler J, Tyedmers J, Bukau B, &amp; Mogk A (2012). Hsp70 targets Hsp100 chaperones to substrates for protein disaggregation and prion fragmentation. The Journal of Cell Biology, 198(3), 387&#x2013;404. 10.1083/jcb.201201074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201201074</ArticleId><ArticleId IdType="pmc">PMC3413357</ArticleId><ArticleId IdType="pubmed">22869599</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirths O, Multhaup G, &amp; Bayer TA (2004). A modified beta-amyloid hypothesis: Intraneuronal accumulation of the beta-amyloid peptide&#x2014;The first step of a fatal cascade. Journal of Neurochemistry, 91(3), 513&#x2013;520. 10.1111/j.1471-4159.2004.02737.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2004.02737.x</ArticleId><ArticleId IdType="pubmed">15485483</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi A, &amp; Kitajo K (2012). The effect of PRMT1-mediated arginine methylation on the subcellular localization, stress granules, and detergent-insoluble aggregates of FUS/TLS. PLoS One, 7(11), e49267 10.1371/journal.pone.0049267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0049267</ArticleId><ArticleId IdType="pmc">PMC3496700</ArticleId><ArticleId IdType="pubmed">23152885</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Yang H, &amp; Tien P (2006). In vitro self-propagation of recombinant PrPSc-like conformation generated in the yeast cytoplasm. FEBS Letters, 580(17), 4231&#x2013;4235. 10.1016/j.febslet.2006.06.074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2006.06.074</ArticleId><ArticleId IdType="pubmed">16831424</ArticleId></ArticleIdList></Reference><Reference><Citation>Young K, Jones CK, Piccardo P, Lazzarini A, Golbe LI, Zimmerman TR Jr., et al. (1995). Gerstmann-Straussler-Scheinker disease with mutation at codon 102 and methionine at codon 129 of PRNP in previously unreported patients. Neurology, 45(6), 1127&#x2013;1134. 10.1212/wnl.45.6T127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.45.6T127</ArticleId><ArticleId IdType="pubmed">7783876</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaarur N, Xu X, Lestienne P, Meriin AB, McComb M, Costello CE, et al. (2015). RuvbL1 and RuvbL2 enhance aggresome formation and disaggregate amyloid fibrils. The EMBO Journal, 34(18), 2363&#x2013;2382. 10.15252/embj.201591245.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201591245</ArticleId><ArticleId IdType="pmc">PMC4570522</ArticleId><ArticleId IdType="pubmed">26303906</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambrano R, Conchillo-Sole O, Iglesias V, Ilia R, Rousseau F, Schymkowitz J, et al. (2015). PrionW: A server to identify proteins containing glutamine/asparagine rich prion-like domains and their amyloid cores. Nucleic Acids Research, 43(W1), W331&#x2013;W337. 10.1093/nar/gkv490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv490</ArticleId><ArticleId IdType="pmc">PMC4489250</ArticleId><ArticleId IdType="pubmed">25977297</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Park YN, Todor H, Moomau C, Masison D, Eisenberg E, et al. (2012). Sequestration of Sup35 by aggregates of huntingtin fragments causes toxicity of [PSI+] yeast. The Journal of Biological Chemistry, 287(28), 23346&#x2013;23355. 10.1074/jbc.M111.287748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.287748</ArticleId><ArticleId IdType="pmc">PMC3390612</ArticleId><ArticleId IdType="pubmed">22573320</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou XZ, Kops O, Werner A, Lu PJ, Shen M, Stoller G, et al. (2000). Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Molecular Cell, 6(4), 873&#x2013;883. 10.1016/s1097-2765(05)00083-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1097-2765(05)00083-3</ArticleId><ArticleId IdType="pubmed">11090625</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L, Xu M, Yang M, Yang Y, Li Y, Deng J, et al. (2014).An ALS-mutant TDP-43 neurotoxic peptide adopts an anti-parallel beta-structure and induces TDP-43 redistribution. Human Molecular Genetics, 23(25), 6863&#x2013;6877. 10.1093/hmg/ddu409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu409</ArticleId><ArticleId IdType="pmc">PMC4245047</ArticleId><ArticleId IdType="pubmed">25113748</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T, Liu Y, Banez-Coronel M, Reid T, Pletnikova O, Lewis J, et al. (2013). RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proceedings of the National Academy of Sciences of the United States of America, 110(51), E4968&#x2013;E4977. 10.1073/pnas.1315438110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1315438110</ArticleId><ArticleId IdType="pmc">PMC3870665</ArticleId><ArticleId IdType="pubmed">24248382</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwilling D, Huang SY, Sathyasaikumar KV, Notarangelo FM, Guidetti P, Wu HQ, et al. (2011). Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration. Cell, 145(6), 863&#x2013;874. 10.1016/jxell.2011.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/jxell.2011.05.020</ArticleId><ArticleId IdType="pmc">PMC3118409</ArticleId><ArticleId IdType="pubmed">21640374</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>